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Abstract 
 This study is designed as the building of a foundation in standardizing best practices 
when designing Direct-to-Consumer messaging.  With this being a new and expanding field of 
marketing and advertising for the high visibility pharmaceutical industry, an establishment of 
conceptual templature, around which Direct-to-Consumer messaging campaign can be built, 
offers an opportunity to build a new and vibrant branch on the well-established messaging field.  
This is particularly important when recognizing the unique needs and requirements of both the 
pharmaceutical industry and its audience in learning of and about new products. 
 This study attempted to identify current perception of Direct-to-Consumer practices by 
industry laypersons with in-depth interviews conducted through a phenomenological framework.  
Participants were interviewed on a range of relevant areas, including directly regarding their 
perception as well as a broader collection of their thoughts and impressions. 
 The results of this study show clear areas of interest, identifying various tactics and 
strategies employed within Direct-to-Consumer messaging and pointing to areas of potential 
perception cultivation by those crafting the message.  The study also uncovered the presence of 
the Third-Person Effect playing a key role in determining the response of participants on 
perception, and potentially opening the door for integrated methods that have been developed 
with Third-Person Effect in mind when building messages.  This study offers a significant first-
step of study into the phenomenon of Direct-to-Consumer advertising, as well as a foundation 
upon which future, larger scale, and more generalizable research can be done. 
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Chapter 1: Introduction 
 The 1980s marked a shift in the way consumers interacted with the pharmaceutical 
industry as direct-to-consumer (DTC) advertising of prescription drug products became prevalent  
alongside the more traditional advertising to physicians and healthcare professionals (Aikin, 
2004).  This was a change in the dynamic between laypersons and the healthcare industry, as it 
offered consumers the opportunity to learn about the use, risks, and benefits of their medications. 
Providing information that had previously been aimed solely at healthcare professionals allowed 
for a greater level of access and investment by consumers into their personal health management.  
Rather than needing to either do a great deal of research, a daunting task in a pre-Internet world, 
or trust in their prescribing physicians without knowing the information personally, consumers 
could now become informed of what products were available and shape opinions on what they 
thought best for themselves. 
 This development offers an interesting dynamic; while the pharmaceutical industry is 
required to speak truthfully in advertising, highlighting the major risks inherent to the drug in 
language the consumer could easily understand (Ventola, 2011), it still serves as advertising, 
focusing on cultivating good will and a positive perception by consumers, which would then lead 
to greater sales, exposure, and profits.  These facts in mind, it would seem beneficial to answer 
the question: 
RQ1: How is DTC advertising perceived as a source of information? 
This question can offer insight into the actual consumptive purpose of the advertisements, 
identifying the experience of the targeted public and their perception of the message, whether 
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consumers use the messaging to gather information or purely as a commercial advertisement.  
This would then lead to a further question: 
RQ2:  How do consumers perceive current messaging strategies? 
In essence, this question cuts to the practically applicable purpose of this study.  Utilizing 
the two previous perceptions of the messaging, as a source of information or as advertising only, 
the study attempted to identify whether there are identifiable patterns in how messages are 
received by the consumer.  The answer to this question can offer insight for the industry into how 
future messaging should be built, depending on the internally determined purpose of advertising.  
The study also attempted to answer: 
RQ3:  Does DTC advertising influence consumer perception of the communicating 
company? 
By answering this question, the study sought to define the experience of the consumer 
and how it affects the relationship between consumer and advertiser.  These three questions 
served as a foundational outline for the way the study was designed, allowing for information 
gathered to be focused into a cohesive set of results.  The answers to these questions can build 
off one another to explore the overall phenomenon of DTC advertising of pharmaceutical 
products as well as the more specific topic of what strategies can be utilized to build a better 
message. 
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Chapter 2: Literature Review 
Utilizing a phenomenological approach to this type of study is a well-worn and validated 
path.  While the small sample sizes and exploratory nature of this approach prevent results from 
serving as definitive proof of concepts, the approach allows a different range of possibilities.  In 
essence, this approach allows for the research to define an area of thought or focus future 
research through the collection of thought or opinion surrounding the topic.  A 2013 paper by 
Cooney, Murphy, and Sixmith attempted to explore and define the use of phenomenology a 
means of doing substantive research.  This paper lays a strong foundation for what 
phenomenology is and attempts to do, stating “It is a way of describing phenomena as they 
appear to the person experiencing the phenomena” (Tuohy, p.18).  The paper focuses on laying 
the groundwork for using phenomenology as an interpretive approach to individual experiences, 
asserting that “As the focus of interpretive phenomenology is to explore the lived experience, it 
is important to recognise that people’s realities are influenced by the world in which they live; 
the researcher needs to understand that experiences are linked to social, cultural and political 
contexts” (Tuohy, p.19).  The researchers, through study of the established body of work on 
phenomenology, concluded that “An interpretive phenomenological approach is suitable for 
research that aims to understand and interpret participants’ experiences, to determine the 
meaning of the experiences” (Tuohy, p.20). 
A 2012 paper by Converse attempts to take this idea of phenomenology and identify how 
it can be used, not only from a theoretical standpoint, but in identifying tactics to use when 
applying a phenomenological approach.  Specifically, the study hones in on the use of in-depth 
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interviews, the strategies in building these interviews, and the process of sampling.  The study’s 
author, Converse, explains that, through interview “the researcher focuses on the phenomenon as 
experienced by the participant” (Converse, p.31).  Converse goes on to identify the value of these 
interviews, stating “During the indepth interviews, the participant reflectively recalls their 
experience with prompting of the researcher to bring light to the meaning of the experience.  
Each participant has a unique meaning of the lived experience of the phenomenon which the 
researcher gathers in order to come to understand the phenomenon” (Converse, p.31).  
Converse’s paper in particular informs the process by which the interview script (Appendix A) 
and selection criteria were developed for this proposed study. 
Many studies have been done showcasing the use of phenomenological theory in 
research, particularly as relates to ideas of perception.  A 2011 paper by Tul, Unruh, and Dick 
attempted to explain the effect that yoga could have on lessening chronic pain.  Data was 
gathered through interviews of subjects with an eye open themes or concepts that emerged as 
universals or generally present.  This led to an understanding of beneficial effects of yoga 
stemming from a mental modification as opposed to an actual lessening of pain.  This in turn can 
act as a launching point for future studies to explore the actual efficacy of the practice.  This 
concept is continued in a 2013 paper by King, wherein the researchers used in-depth interviews 
to attempt to define a particular phenomenon.  In this case, the researchers were looking to gain 
insight into “the relevance of socializing agents on adolescent identity development and the need 
for continued global support for individuals with multiple, marginal, fluid identities” (King, 
p.308).  The study identified areas of concern, highlighting key factors to the phenomenon while 
laying the groundwork for future, more specified and focused studies in order to definitively 
explain concepts.  This type of identifying process is further validated in a 2010 paper by Crotser 
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and Dickerson, in which researchers attempted to understand the ways in which a layperson can 
respond to communication of medical information, the process by which it is received, and the 
contributing factors to perception.  The paper also explicitly states that “future research is 
indicated” (Crotser, p.367), highlighting the fact that, again, this approach benefits from a strong 
background in use as foundational research attempting to guide future thought. 
There is also a place for phenomenology when attempting to build a more ambitious 
study.  In a 2013 paper by Vakich, Lowes, Niles, et al, researchers attempted to understand the 
way humanity as a collective is represented by its messaging to an unknown outside force.  The 
researchers collected data and information surrounding the topic, compiled the messages sent out 
through a program designed to attempt contact with extraterrestrial life, and analyzed it looking 
for commonalities or prevailing ideas.  This study did not look to solely lay the groundwork, 
instead attempting to build out a cohesive and thorough idea on its topic.  This is further seen in a 
2008 paper by Aho, in which researchers, through a thorough study of the pharmaceutical and 
psychiatric industries, attempted to identify and define the limitations of industry professionals 
as well as some possible industry norms that may be outdated or wrong.  In these two cases, the 
phenomenological approach is used to delve into a subject, offering the researchers something 
tangible with which to go about exploring an established idea.  These two approaches in mind, 
the adaptability of phenomenology allows for the possibility that, should a foundational or 
exploratory study into an unresearched or under-researched field can quickly shift gears to a 
more ambitious and comprehensive study. 
It is important to note that, while the pharmaceutical industry is a well-researched field, 
the particular area of direct-to-consumer advertising and its relation to public perception is a 
completely untouched concept.  Further, the field is replete with quantitative studies exploring 
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efficacy of drugs, hard numbers, figures, or statistics, and very little in the way of exploration of 
messaging.  Particularly, the perception of the consumer is left untouched, as some in-industry 
research has been done.  In a 2010 paper by Srivastava and Sahrma, researchers attempted to 
identify how people working within the pharmaceutical industry strategically design the message 
seen by the consumer.  And yet, the researcher never went to the consumers themselves, instead 
finding what the industry perceives as important for the consumer to hear, see, and know.  This 
theme is continued in a 2008 paper by Crigger, Barnes, et al, in which the researchers 
interviewed and observed the communication between pharmaceutical companies and nurse 
practitioners.  This was done as a way of cataloging the determining factors amongst healthcare 
professionals on perception of marketing strategies.  This angle is also seen in a 2003 paper by 
Wright and Lundstrom, which built around the relationship between physicians and sales 
representatives from the pharmaceutical companies.  Again, we see an examination of 
professional-to-professional communication and perception, never getting an idea of how the 
consumer is influenced and what determining factors shape their perception. 
In papers done exploring the role of the consumer, the focus has largely been on 
perception of a particular type of medication.  In a 2013 paper by Green, Horne, and Shephard, 
the researchers attempted to identify whether labeling of a drug, such as natural remedy, 
pharmaceutical, or personalized medicine.  This test identified predictable patterns by which 
perception of the type of drug could be determined, essentially finding that risk versus reward 
played pivotal roles in a patient’s willingness to use a type of drug.  However, this does not 
attempt to explain how messaging from the pharmaceutical industry can affect perception when 
unable to alter the labeling.  This is continued in a 2012 paper by Danjulaityte, Falck, and 
Carlson, in which researchers attempted to define the determination of perception of risk by 
 7 
 
users of a drug.  This study found, among other things, that illicit use of prescribed drugs is 
viewed as more acceptable than use of non-prescription medicine.  However, this is again not 
defining perception of the messaging, or the industry at all, simply the use of drugs for non-
prescribed purposes. 
Beyond study of the pharmaceutical industry, looking into the specific area of DTC 
advertising, some key defining research has already been done.  A 2004 paper by Aikin was 
tasked with identifying the way DTC advertising is received and the way it is perceived, as a 
concept, by consumers and physicians.  The study compiled two phone surveys of consumers, 
one done in 1998 and the other in 2002, which identified, among other findings, that a majority 
of consumers believed the advertising “felt the ads provide enough information to make a 
decision about whether to discuss the drug with a doctor,” (Aikin, p.3), however it should be 
noted that this number had declined year over year. 
Further, it was found that nearly a third (32%) of respondents “felt the ads help them 
make better health decision” (Aikin, p.4).  However, the study also found that “60 percent felt 
the ads do not provide enough information about risks,” (Aikin, p.4) and 58% “believed the ads 
make the products seem better than they are,” (Aikin, p4).  Essentially, the study found a 
disconnect between consumer opinions of the concept of DTC advertising, viewing it as a 
positive idea, and the practical application of this messaging, perceiving their experience with it 
as having positive and negative traits.   
In a 2011 paper by Ventola, the researcher looked into the part that DTC advertising 
plays in the healthcare marketplace.  The study first outlined the history of DTC advertising, 
using this background framework to launch into an exploration of what this form of messaging 
offers to consumers and what arguments exist both for and against it.  What was found was that, 
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on the one hand, this form of advertising promotes an opening of lines of communication 
between consumers and healthcare providers, inspiring a more informed consumer populace and 
reducing the incidence of illnesses and diseases going undiagnosed, undertreated, or sufferers 
facing social stigma relating to their condition.  However, the study also found that this form of 
advertising can result in patients being under-informed or misinformed regarding drugs and 
conditions, can result in overemphasis on treatment through prescription, can strain relationships 
with healthcare providers, and lead to inappropriate prescribing.  These two papers do a good job 
of laying the groundwork for understanding DTC advertising and the role it plays in the 
healthcare industry.  However, neither looks into effects on perception of the pharmaceutical 
industry or specific messaging strategies, instead focusing on how consumers use the advertising 
to interact with physicians. 
The study proposed in this paper is designed to fill a void in the literature involving DTC 
advertising, specifically as it relates to how messaging can be standardized to find a predictably 
positive reception.  A 2005 paper by Wosinska offers a glimpse into the role that this particular 
form of advertising plays in the marketplace.  Author Marta Wosinska attempted to identify the 
relationship between DTC advertising and consumer compliance with prescribed therapy.  The 
study notes that “Poor compliance with prescribed therapy cost pharmaceutical companies $15-
$20 billion annually” (Wosinska, p.331).  This in mind, the ability to influence consumers to 
improve adherence rates exists as a primary goal of the industry.   
What was found was that, on one hand, DTC advertising has a rather small influence on 
consumer compliance to prescribed drug therapy. DTC messaging was “not found to be 
particularly effective in increasing compliance compared with other drivers, such as time-
invariant brand quality and severity of condition” (Wosinska, p.332).  However, the study 
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concluded that “even minimal sales resulting from improved compliance are a win” (Wosinska, 
p.332) while contending that “a properly designed compliance campaign could be more effective 
than secondary compliance effects of acquisition campaigns” (Wosinska, p.332).  This, in 
essence, cuts to the core of the proposed study as, Wosinska is concluding that a shift in 
messaging to a more compliance focused model could offer ever greater economic benefits than 
the currently used models designed to increase number of users.   
However, in the body of knowledge developed after this paper, the focus has tended to be 
on the people receiving the message, rather than the messaging itself.  A 2008 paper by Sheng 
Yuan attempted to build a foundation for predicting the effectiveness of DTC advertising.  This 
was done through interviewing of an adult sample, questioning how those interviewed view DTC 
advertising in general, and attempting to identify predictors from the collected data.  Yuan found 
that personal demographics, factors like age and education, could predict how the person 
interviewed would perceive DTC advertising as a concept.  The study does not, however, give 
insight into what strategies can be used to build successful messaging, instead focusing on 
finding patterns in types of consumers.  This has tended to be the general direction of research; 
when not focusing on the perception of the physician or effects on the patient/physician 
relationship, studies have looked into what kind of people can be seen as most positive or 
negative, from a demographic standpoint, toward the concept of DTC advertising.  The area of 
messaging strategy, on the other hand, has been largely ignored by researchers, leaving a void in 
the literature. 
Before proceeding to the Methods section, it is important to briefly define the research 
questions being posed, as well as some of the verbiage being used.  As a whole, the research 
questions are deigned to deliver a complete picture of Direct-to-Consumer advertising, 
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identifying the various purposes and perceptions of the phenomenon.  RQ1 seeks to identify 
consumer perception with regards to informational value, developing a baseline understanding of 
the perception of DTC advertising.  This is important to establish as, at its core, this question of 
perception determines the current state of the phenomenon.  As the study seeks to identify and 
standardize how DTC is designed, it is an essential step to understand how the phenomenon is 
currently perceived.  This allows those creating the messages to better understand whether 
current strategies are cultivating the desired effect.  RQ2 is a much narrower question, looking 
not at the overall phenomenon, but at the individual strategies used within the advertising.  By 
identifying, not only what these strategies are, but how they are perceived, will allow for 
designers to better direct future efforts.  With the intention being to establish rules and 
templature for DTC advertising, it is a vital step to identify what is working and what isn’t.  RQ3 
then moves to the next step, examining the impact of the phenomenon on the communicating 
company.  While it is essential to answer the questions posed by RQ1 and 2, RQ3 attempts to 
answer the question of responsible use.  As with any tool, it is important to understand, not just 
how the tool works, but what the outcome of use is. 
With regards to verbiage, there are three words in this study that need to be defined, as 
they are words with multiple uses in general speech, but are being used very specifically in this 
study: drug, information, and strategy.  When speaking of drugs, in this study, the word is used 
to mean “a natural or synthetic substance used in the prevention of disease, a medicine” (OED, 
2015), and more specifically, this study is concerned with drugs that are available by prescription 
only, not over-the-counter.  It is important to make this distinction, as this study is looking only 
at these products, and not “a substance with intoxicating, stimulant, or narcotic effects used for 
cultural, recreational, or other non-medicinal purposes.  A controlled substance used illegally and 
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often habitually” (OED,2015).  This study is also not looking at drugs in the broadest sense, 
meaning “any substance, of animal, vegetable, or mineral origin, used as an ingredient in 
pharmacy, chemistry, dyeing, or various manufacturing processes” (OED, 2015).  By keeping 
the scope of the definition narrow, the researcher can prevent the potential derailing of this study 
by discussion over non-relevant issues.  The use of “information” in this study is much more 
straightforward, as it is being specifically used to refer to an educational use.  When, in RQ1, the 
word information is used, it is asking whether consumers of DTC advertising perceive the 
phenomenon as an educational experience, or perhaps a more passive or entertaining one.   
Finally, when using the word “strategy” and its derivatives, this study is referring to messaging 
strategies employed within specific examples of DTC advertising.  This means, for example, 
concepts ranging from celebrity endorsement and art direction to tone.  “Strategy,” as a concept, 
is being used solely within the context of the DTC advertisements themselves throughout this 
study. 
An additional point of note is the nature of regulations on what is allowed, required, and 
forbidden within DTC advertising.  First, there is a distinction between OTC, or over-the-counter 
drugs and prescription drugs, as the FDA only regulates the latter, whereas the FTC regulates the 
former (FDA, 2015).  As this study is focusing on prescription drugs, the FTC regulations are not 
necessary to consider.  The FDA requires only three things to be included in DTC advertising: at 
least one approved use for the drug, the generic name of the drug, and all risks of using the drug, 
with available exceptions to the final point under certain circumstances (FDA, 2015).  Beyond 
these three requirements, advertisers are forbidden from certain things, mainly having to do with 
making specific claims that are unsubstantiated or deceitful.  The final requirement is in the 
realm of ad design, stating “The layout of an ad – the way information is presented – can affect 
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whether an ad meets the fair balance requirement” (FDA, 2015).  The fair balance requirement is 
a law that “requires that product claim ads give a ‘fair balance’ of information about drug risks 
as compared with information about drug benefits.   This means that the content and presentation 
of a drug’s most important risks must be reasonably similar to the content and presentation of its 
benefits” (FDA, 2015).  The language herein is very specific in the things that are allowed, 
forbidden, and required, which does place some limits on how advertisers can employ language 
and symbols in designing their advertisements.  However, the language does also offer 
interpretation in stating about the Fair Balance requirements, “This does not mean that equal 
space must be given to risks and benefits in print ads, or equal time to risks and benefits in 
broadcast ads.  The amount of time or space needed to present risk information will depend on 
the drug’s risks and the way that both the benefits and risks are prevented” (FDA, 2015).  
Coupling this alongside the FDA’s largely hands-off approach to monitoring, in which the FDA 
does not review and approve all ads before release, limit the drugs allowed to be advertised, the 
language used, or the money spent on campaigns (FDA, 2015), there exists quite a bit of room 
for discretion on the part of the advertiser. 
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Chapter 3: Method 
Methodology 
Phenomenology, being a school of thought founded in the subjective world of the 
subject’s perception, enables research to be done that focuses on individual thought.  Through 
the analysis of this personal thought and the synthesis of thoughts from different individuals, 
conclusions can be drawn, finding patterns or themes regarding how perception is built.  A 2013 
study exploring how “synthetic life” is perceived used phenomenology as the primary 
mechanism.  Asserting that “perception itself is obviously also a part of our own experience of 
embodiment” (Rehmann, p.20), the researcher then built out a definition of “life” around the 
definition of phenomenology.  In essence, the study was designed to offer a working idea of what 
“life” is by approaching from an experiential standpoint, rather than a biological one.  As relates 
to the study of DTC advertising, this is an important point, in that it offers a launching point from 
which we can justify perception and experience as determining factors in successful messaging.  
Digging through a long, and strongly defined history of phenomenology as a theoretical 
launching point, there are countless examples, both conceptual and practical, that validate the use 
of phenomenology, and in turn, the perceptions defined through it, as a barometer for success 
and a guiding force for cultivating more complete and thorough success. 
Moving to the particular mechanism of this study, it has been shown that deep and 
meaningful information can be synthesized through in-depth interviews with a relevant public. A 
2014 study on identification of students with hearing loss as “Deaf” or “Hard of Hearing” 
utilized a phenomenological framework and in-depth interviews in order to identify perception 
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within a defined community.  The researchers posited that, “only through interviewing 
caregivers/parents about perceptions of identity and hearing loss in the students can the 
researcher learn of prior experiences that contribute to definitions of hearing loss and impact of 
hearing loss on the family unit that may affect how the caregivers/parents identify and perceive 
their children in relation to hearing loss” (Kemmery, 2014).  While the specific subject matter 
differs greatly from the subject of this study, the intention is quite similar.  By interviewing 
experiencers of the phenomenon, parents/caregivers and consumers of DTC advertising 
respectively, rather than the specific source of the phenomenon, the students with hearing loss 
and the pharmaceutical industry respectively, it is possible to understand how and why 
perception is defined.  In the case of this particular study, interviewing laypersons with no 
professional experience in pharmacy allowed the interview to focus solely on identifying 
determining factors of perception obtained through messaging, without having to consider the 
intention of the professionals who designed the message. 
It should also be noted, briefly, that, by utilizing a phenomenological framework, this 
study was designed to grow and evolve organically.  Though the mechanism used was 
standardized in order to centralize the results, the study was allowed to grow and find results 
beyond those initially stated, should they be relevant.  This was done in order to enhance this 
study’s viability as the foundation of a broader field of inquiry, allowing researchers to identify 
and pursue a wider array of study with regards to DTC messaging, rather than constraining the 
findings to those originally posited. 
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Participant Selection 
Subject selection was based on two main criteria: an age minimum of 20 and maximum 
of 59 and familiarity with the pharmaceutical industry.  For the first point, the age-gate is in 
place to verify that all subjects are capable of representing themselves and that they have the 
ability to seek personal healthcare without requiring parental consent.  Furthermore, this age 
range was chosen because it represents a sharp jump in prescription drug use.  A study by the 
CDC found that  48.3 percent of people in this age group use prescription drugs, as opposed to 
29.9 percent in the 12-19 demographic (Gu, 2010).  This factor ensured that information 
collected is useable and begin the process of ensuring relevance to the desired goals.  The second 
point is designed to ensure that any subjects chosen for interview was knowledgeable with 
regards to the subject at hand while increasing the likelihood of both personal exposure to DTC 
messaging and a subjective perception of the industry and the concept of DTC messaging.  ‘ 
There were four criteria for exclusion of participants: not meeting either of the selection 
criteria, being themselves or directly related to a pharmaceutical industry professional, having a 
history of abuse of prescription drugs, and having no knowledge of or interaction with the 
pharmaceutical industry.  The first criterion is in place to simply ensure that the selection criteria 
are met.  The second criterion is in place to ensure that any subjects chosen for interview are, in 
fact, laypersons indicative of a general perception.  This negated the possibility of perception 
being determined by factors beyond DTC messaging, such as personal bias honed through 
employment in the industry.  The third criterion is meant to ensure that any subjects interviewed 
are approaching the pharmaceutical industry from a legal and healthy perspective, are familiar 
with the industry for reasons that do not include chemical dependency, and are possible target 
audience members for the proper use of advertised medications.  The final criterion ensured that 
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any participants taking part in the interviewing was familiar with the industry and its messaging 
and can reasonably be expected to maintain an informed opinion.  Through these methods of 
selection and exclusion, interviews conducted should be free from recognizable anomalous 
behavior.  Multiple interviews were conducted in order to confirm recognizable trends or themes, 
if any are present. 
Interviews were conducted following a predetermined interview script (Appendix A) in 
order to focus questioning.  The script is designed to gather information methodically, 
standardize the interview experience (thus neutralizing the effect of the interviewer on the 
subject), and provide an outline for the ideas and concepts that need to be explored.  That in 
mind, the script was not followed by the letter as the interview was allowed to go at the subject’s 
pace while attempting to cultivate genuine perception and mentality, rather than forcing subjects 
to follow the interviewers train of thought.  This may include deviation from question order as 
well as inclusion of supplemental questions to explore ideas or concepts discovered through the 
interviewing process.  Interviews were recorded for audio only, subjects were told of this 
beforehand while signing an informed consent form (Appendix B).  Before beginning the 
recording, subjects were offered the chance to pull out of the study as well as offered the 
opportunity to pull their participation from the study at any point during or after the interview, 
the result of which would be the deletion of the interview recording in their presence and the 
removal of their presence from any study materials. 
An initial participant pool of 18 participants volunteered to take part in the study as 
interviewees.  Of these 18 participants, 11 were disqualified under criteria established within the 
exclusion criteria.  Of the remaining seven participants, one chose to withdraw participation 
midway through their interview and one participant asked to withdraw several weeks after their 
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interview.  This posed somewhat of an issue, as the shrinking participant pool alongside the 
withdrawn interviews pushed the number of interviews conducted and usable to five.  That being 
said, there are two major reasons for which this exists as a sufficient data set for the study; the 
study’s purpose and the nature of remaining interviews.  From the beginning, this study was 
designed as a conceptual framework upon which to build future research.  Participant numbers 
were purposefully kept small as a means of identifying broad trends in order to make future, 
quantitative research, more directed and focused.  While the final number was smaller than 
initially planned, it obtained success in this proposed intention, as the remaining interviews offer 
clear concepts upon which future research can be based.  While this study could possibly be 
broadened by further data collection, doing so would be an inefficient use of time.  The time 
would likely be better served collecting data through a larger, statistics based study of the themes 
identified within this study as it stands. 
Those interviewed were questioned about their familiarity with the industry, seeking to 
eliminate subjects with too much familiarity (professionals, students of the field, etc.) as well as 
those from whom information gathered would not provide meaningful insight (those with little or 
no interaction with the pharmaceutical industry or its messaging).  From here, the aim would be 
to obtain information regarding the specifics of the person’s relationship and interactions with 
the industry, the specifics of their perception, and the specifics of messaging observed or 
received.  Through this collection of information, the goal would be to synthesize disparate 
thoughts and ideas from the various participants in the hopes of finding discernible patterns or 
predictive factors. 
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Chapter 4: Results 
 Through the five interviews, certain trends became evident, supporting certain ideas 
while leading away from others and casting more questions for future study.  For the most part, 
responses addressed three major areas: perception of familiarity, perception of effectiveness, and 
perception of best practices.  For the case of this study, these three areas serve as pillars, around 
which baseline assumptions can be and quantitative study can be based. 
 Early in all interviews, participants were asked questions regarding their familiarity with 
direct-to-consumer advertising.  The questions were asked in multiple ways in order to adjust for 
personal perception.  When initially asked, “How would describe your personal level of exposure 
to DTC Advertising,” responses ran a wide gamut, one respondent stating, “It’s (DTC 
Advertising) just not a part of my life,” while another lamented “I can’t seem to escape them 
(DTC Advertising), no matter what I do.”  Overall, two of the respondents noted a general 
unfamiliarity with DTC Advertising, while the remaining three all defined varying levels of 
frequent familiarity.  When presented with an opportunity to define familiarity along a polar, 
linear scale, the respondents, regardless of response, immediately placed themselves with the 
realm of familiarity or unfamiliarity.  
Later on in the interview, all respondents were asked to identify specific examples of 
DTC Advertising, having discussed the concept and understanding what it entails.  The 
responses to this question painted a much different picture than the earlier responses by soliciting 
the information in a different manner.  In response to this question, regardless of personal 
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perception of familiarity, all respondents were able to list off a number of examples of DTC 
Advertising, many of which were duplicated across respondents.  The various respondents 
referenced Viagra, Cialis, Allegra, and Levitra, among others, as common and ubiquitous 
subjects of DTC advertising. 
This is an interesting result as, despite perceived familiarity, despite differences in media 
consumption, both in outlet and levels, respondents were similar in their ability to identify DTC 
Advertising to which they’d been exposed.  This delineation of perception and reality marks a 
point of future study, highlighting a real-world difference between how advertising is perceived 
and the actual impact it has as well as the general perception of what advertising is as a concept 
through the eyes of non-industry professionals.  Essentially, while the industry works to build 
specific definitions in order to identify what does and does not work, the public would seem to 
ignore these definitions while still exhibiting signs that the advertising has been effective.  It 
must be noted that this is evidenced through five interviews and would need to be explored on a 
much larger scale in order to be quantified.  It would, however, be irresponsible to ignore the 
dichotomous phenomenon occurring here that allows a message to be simultaneously ignored 
and received. 
 Responses to perception of best practices were the most difficult to unravel, though 
possibly the most rewarding, as the respondents addressed several areas consistently, doing so, 
however, with varying approaches and ideas.  Tone, imagery, and detail of information were all 
points of focus for the respondents, while concepts like celebrity endorsement and the ubiquitous 
fine print were brought up by several respondents. 
 Tone and imagery were largely viewed as interconnected concepts with similar goals, 
points of focus, and concerns.  Specifically speaking, these concepts were seen as reliant on the 
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purpose of the advertised drug in order to direct the applied tone and imagery.  This mentality 
was best summarized by a respondent who stated, “there was one, I don’t know what company, 
but they used cartoons, and it was like animated, and I didn’t think that was like appropriate 
because, like, it wasn’t for kids, so it wasn’t like, it was like for, it was an adult medication, but I 
don’t feel like cartoons, they’re like, necessarily the appropriate way because they just take the 
seriousness out of it, so it’s just a joke to me, is how I perceived it.” 
Individually, the respondents had varied opinions on the limitations of what is 
appropriate, one respondent stating “Cartoons just shouldn’t be used.  Drugs are serious so you 
shouldn’t use something silly to sell them,” while another respondent stated “It doesn’t have to 
be all gray and monotone and boring, it just has to make sense why you’re being, maybe, less 
serious like Flintstone Vitamins.”  However, with a fair bit of uniformity, the respondents agreed 
that advertisers should cater the taste of the advertisement to the maturity and severity of the 
drug being advertised.  This was much the same rationale as used by a respondent who 
questioned the relevance and propriety of using celebrity endorsements in DTC Advertising.  
This respondent stated, “If I’m going to take a new drug, I want to hear a doctor or someone who 
has gone to school for a long time.  I don’t want to hear a TV star from the 70s or a Hollywood 
actress with arthritis.  It just feels manipulative.”  This respondent went on to explain that, while 
the subject matter is serious and very technical, having a celebrity selling the drug is just a 
“marketing ploy” rather than informative. 
 Detail of information was another point of conflict, with the only common thread being 
that no respondent thought current information tactics were tuned properly.  Breaking down the 
numbers, three respondents believed there should be more information provided in DTC 
Advertising while the remaining two respondents thought the current level of information to be a 
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bit overwhelming.  One respondent in the first group noted “If the idea is to inform the 
consumer, why aren’t the advertisements full of information?  Shouldn’t there be more details if 
they’re actually trying to educate us?”  Another stated, “Sometimes I feel like it’s just another 
commercial, but if I really think about it, I want to know way more about a pill than about a hose 
that fits in my pocket.”  On the other end of the spectrum, one respondent related, “I have really 
bad allergies and it seems like every day there’s a new drug for me and I just get burnt out on it.  
I’d rather they just tell me what’s new and let me look up the information if I want to.”  The 
other respondent in favor of lessening the amount of information stated, “Nobody really learns 
anything from this stuff, it just makes them think they know more that their doctors.   There’s not 
enough information to be helpful, just misinformed.” 
 Though it seems contradictory, one of the respondents who promoted lessening the 
amount of information provided proposed expanding the presence of potential side effects in 
DTC Advertising.  “I don’t need to know how it works or how many extra hours I’ll be able to 
sleep or whatever, I can look that up, but I would like to know if the drug will cause my hair to 
fall out or give me a heart attack.  It shouldn’t just be this tiny font or someone speed-whispering 
at the end of a commercial.”  Though only three of the respondents broached this topic, all three 
agreed that this information was essential in DTC Advertising. 
 
Third-Person Effect 
Regarding perception of effectiveness, respondents were conflicted, the tool of the 
interview somewhat letting down the ability to collect information. This is seen in the fact that, 
when asked whether they believed DTC Advertising was an effective method of messaging, all 
respondents skirted the issue by detailing the ways in which DTC Advertising would be effective 
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to others, but not themselves.  One respondent stated, “I’m kind of immune to advertising at this 
point in my life, but I feel like it would work for most people,” while another stated, “It 
obviously works, I don’t know if it works on me, but it obviously works for most people.” 
Across the boards, the responses tended to validate the previously studied and well 
established Third-Person Effect.  First studied in the early 1980s, it found “that people will tend 
to overestimate the influence that mass communications have on the attitudes and behavior of 
others.  More specifically, individuals who are members of an audience that is exposed to 
persuasive communication (whether or not this communication is intended to be persuasive) will 
expect the communication to have a greater effect on others than on themselves” (Davison, p.3). 
The appearance of Third-Person Effect in this study, while unanticipated, was a prevalent 
and powerful mechanism at play.  The actual function of Third-Person Effect was expounded 
upon in a 1996 paper by Vincent Price and David Tewksbury, in which it was posited that the 
effect itself may be nothing more than an artifact of faulty methodology.  The study, viewing the 
use of questions that attempt to quantify the effect on others compared to the effect on oneself 
asks, “First, does the order in which these questions are asked affect the tendency of people to 
report greater media influence on others? Second and even more basic, does the observation that 
perceived impact on oneself is less than perceived impact on others require that both questions 
be asked of respondents?” (Price, p.121).  These questions cut to the core of the Third Person 
Effect; in essence, if these questions are answered affirmatively, the Third-Person Effect would 
not be an actual mechanism of opinion, but an outcome dictated by flawed methodology in data 
collection. 
That study was conducted by asking a series of questions relating to mass media and 
questioned either the Self Only, Others Only, Self then Others, and Others then Self.  By offering 
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these four options, the researchers were able to account for whether the Third-Person Effect was 
present or amplified by the presence of questioning both self and others versus only self or only 
others, and whether the order mattered if questioning both self and others.  The research showed 
that regardless of which set the participants fell into, there was not significant variation in the 
perceived impact of mass media on self or others; the Third-Person Effect showed as present 
throughout. 
This having established the viability of Third-Person Effect as a true mechanism in 
determination of perception serves two purposes in this study: to validate that an outcome 
showing the presence of a Third-Person Effect does not point to a problem with the 
methodology, and the existence of a factor in the standardization of DTC messaging that is 
educational and potentially possible to manipulate.  This is further borne out in a 1996 study by 
Hans-Bernd Brosius and Dirk Engel, in which the origin of Third-Person Effect was explored.  
The researchers attempted to find how the Third-Person Effect on perception is developed by 
examining its effect on different types of media and in different contexts. 
The study found that the strength of the Third-Person Effect could be reliably predicted 
by the credibility of the media source; high credibility outlets such as the news exhibited a far 
weaker Third-Person Effect than low credibility outlets like commercials and campaign ads.  
Additionally it was found that, in the dichotomy of the Third-Person Effect, opinion of impact on 
oneself is largely determined by the perceived benefit or detriment of the message, while opinion 
of impact on other “is affected by the perceived similarity of the first person with the third” 
(Brosius, p.159).  As the Third-Person Effect exhibits a somewhat predictable force upon 
perception and opinion, it offers an opportunity in designing messages around standardized 
method. 
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Chapter 5: Discussion 
 There are insights and limitations to be found within this study, both of which should be 
taken as lessons for future study, both in the specific area and the utilized methodology.  Certain 
questions ultimately offered little to nothing in the way of useful information, particularly 
questions asking for participants to relate specific experiences they’d had with the 
pharmaceutical industry.  While these questions were designed to serve as potential sources of 
shared experiences between those interviewed, there was ultimately no collating information that 
served to organize respondents.  Additionally, the repetition of the question “How do you 
specifically perceive DTC Advertising as a concept,” early and late in the interview offered no 
real contrast with this subject.  While this was implemented as a way of potentially identifying a 
change in perception stemming from discussing the subject, the participants all reiterated their 
earlier assertions.  This may identify the presence of well-defined perception prior to the 
interview, with the subjects already having decided on their perception of DTC advertising.   
 In order to deliver more generalizable information, it would be highly beneficial to 
modify the study for a wider, quantitative study.  Through interviews, this study was able to 
provide data to respond to the proposed research questions while serving to direct and focus 
future efforts.  Regarding RQ1, looking into the perception of DTC advertising as a source of 
information, the interviews would tend to point out a gap between the current role and the 
desired one.  Respondents seemed to agree that, in its current form, DTC advertising falls 
somewhat short as a source of information.  And yet, the respondents pointed out the value of 
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this information, defining it as more valuable than other commercials, not involving 
pharmaceutical DTC advertising, within the same space.  In essence, while the consumers 
offered ideas of how to better execute DTC advertising, they respected it as an important source 
of information and a valuable addition to the advertising environment. 
 This leads directly into how RQ2 was answered by the respondents.  Reiterating 
statements from the above results section, it is important to note that this question was impacted 
particularly strongly by the mitigating Third-Person Effect.  While a pattern can certainly be seen 
in the way respondents, in one way or another, all deflected their reception of DTC advertising, 
there are important patterns to be found in examination of the finer details.  Future study focused 
on the above-mentioned areas of tone, imagery, detail of information, celebrity endorsement, and 
fine print should offer researchers the ability to build defined and standardized best-practices in 
order to better resonate with consumer perception.  Additionally, by utilizing a large-scale, 
quantitative methodology, the Third-Person Effect can be somewhat nullified through anonymity 
and volume.  By negating the personal relationship to the questions asked, researchers should be 
able to bypass the effect altogether.  A 2014 study examining the effect of varying grammar in 
order to account for the Third-Person Effect can be used as a roadmap for designing future study.  
This study offers a defined resource from which to draw verbiage in neutralizing the Third-
Person Effect.  Additionally, the study found that “individuals are more likely to support public 
policies aimed at improving decision making when the target of such policies seem to be people 
in general” (Cornwell, p.440).  This fact shines light on the part that manipulation of the Third-
Person Effect may be able to play in directing perception in order to standardize best practices.  
As such, while the unexpected appearance of the effect serves to somewhat mitigate the toolset 
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used in this study, it offers a new direction and possibly a strong tool in future research and 
practice. 
 RQ3 stands as highly informative, despite culminating in a negative answer.  Asking if 
DTC advertising influences consumer perception of the communicating company, the interviews 
would tend to show a lack of any real connection between the two.  In essence, while participants 
could readily list off specific drugs, they were unable to connect them to the producing company.  
Ultimately, it is not apparent from this study whether perception of specific companies is a 
widespread enough phenomenon to be valuable in identifying best practices.  Future study may 
find this to be a worthwhile avenue of exploration, however this study tends to show a 
disconnect between observation of DTC advertising and perception of pharmaceutical 
companies. 
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Chapter 6: Conclusion 
 It is important to note that this study does not attempt to offer any proof or definitive 
answers as to how to build a template from which DTC Advertising can be hewn.  Instead, the 
intention was to begin building a foundation for future study while highlighting the successes as 
failures of the practice in its current state.  Through the implemented methodology, this study 
was able to identify fruitful areas for future study, highlighting a cursory glance into the issues of 
DTC Advertising as seen by non-industry professionals.  As a building block in opening a new 
area of interest, this study has succeeded in spite of a few limiting factors. 
The concept of Third Person Perspective exemplifies the purpose of this study, appearing 
unexpectedly, mitigating part of the applied measurement tool but better defining the obstacles 
present in DTC advertising.  Integrating this defined and established concept can help to define 
standardized best practices by offering a data point around which research can understand how 
DTC messages are consumed and perceived.  Future study can determine the extent to which this 
perspective is magnified by participation in the study and potential avenues through which to 
apply tactics necessary to properly direct the effect. 
Speaking toward the effectiveness of this study, the primary outcome is the definition of 
essential areas of future studies and the identification of potential obstacles to obtaining data.  
Based on the acquired information, an ideal proposal going forward would be the development 
of a three pronged study, assessing subjects with regards to perception of familiarity, perception 
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of effectiveness, and perception of best practices independently.  Using a boxed survey 
framework, the variables of which would relate to the particular pillar represented by that arm of 
the study, researchers would be able to collect larger scale, more generalizable information, 
mitigate potential inaccuracies caused by the intimacy of in-person interview, and collect more 
directed and specific data.  By collecting the specified and generalizable data, researchers have 
the potential to develop new theory along the lines of Situational Crisis Communication theory, 
formulizing messaging to be more efficient, accurate, and appreciated. 
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Chapter 7: Study Limitations 
 This study suffers from two major areas of limitation; mitigation of toolset usability and 
scope of generalizability.  Speaking to the first limitation, this directly references the appearance 
of Third Person Perspective as a constant within the study.  This acts as a limitation for the 
simple reason that, though this is a well-studied and defined concept, it has not been previously 
applied to DTC advertising and, as such, was not accounted for in building the toolset used for 
collecting data.  While the identification of its part in this particular messaging concept serves as 
a valuable result, it also somewhat mitigates the results initially intended to be assessed.  The 
second limitation, in essence, is the fact that this study offers limited generalizability.  The data , 
though able to identify concepts of interest in future study, cannot identify patterns within the 
larger population, as the small scope cannot be extrapolated to a larger public.  Though this was 
not an intention of the study, it does serve as a limitation, requiring future, directed study in order 
to overcome. 
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Appendix A 
DTC Interview Script 
Obtain basic demographic Information: 
What is your age? 
Gender: Male/Female? 
Race/Ethnicity? 
Sexuality? 
*************************************** 
1) Define DTC Advertising 
2) How would you characterize your consumption of various forms of media? (I.e. internet, 
television, print, etc.) 
3) What is your relationship with the pharmaceutical industry? 
4) How would you characterize your perception of the pharmaceutical industry? 
5) What resources do you rely upon to receive information regarding healthcare and medical 
therapy? 
6) How do you specifically perceive DTC Advertising as a concept? 
7) How would you describe your personal level of exposure to DTC Advertising? 
8) Can you identify specific advertisements that you would say are particularly well done? 
9) Particularly poorly done? 
10) Tell me a story ---   If DTC Advertising has ever specifically altered your personal 
perception? 
11) Tell me a story ---   If so, when and why? 
12) Having thought a bit about what DTC Advertising is, what examples of DTC Advertising 
are you specifically familiar with?   
13) Do you think DTC Advertising is effective?  Why? 
14) Do you think DTC Advertising works particularly well when used in a specific medium? 
15) Can you identify any specific common strategies you’ve observed as present throughout 
DTC Advertising? 
a. What is your opinion on these strategies? 
16) How do you consider DTC Advertising as a responsible and reliable source of 
information?  
17) What part do you think new media forms, such as internet and social media, should play 
in DTC Advertising? 
18) What role, if any, do you think the government should play in regulating DTC 
Advertising? 
19) How do you specifically perceive DTC Advertising as a concept? 
20) Is there anything else you’d like to say on the subject? 
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Appendix B 
 
 
 
 
 
Informed Consent to Participate in Research 
Information to Consider Before Taking Part in this Research Study 
 
You are being asked to take part in a research study. Research studies include only people who 
choose to take part. This document is called an informed consent form. Please read this 
information carefully and take your time making your decision. This interview involves minimal 
to no risk research regarding perceptions concerning Direct-to-Consumer (DTC) Advertising of 
prescription drugs. 
 
We are asking you to take part in a research study called: 
Developing Strategy in Direct-to-Consumer Advertising 
 
The person who is in charge of this research study is Nicholas Fancera. This person is called the 
Principal Investigator. However, other research staff may be involved and can act on behalf of 
the person in charge.  
 
The research will be conducted at The University of South Florida 
 
Purpose of the study 
The purpose of this study is to examine whether or not patterns can be found in the reception of 
Direct-to-Consumer messaging, and if these patterns can be used to build standardized strategies 
when designing future messaging. 
Study Procedures 
If you take part in this study, you will be interviewed regarding the subject described. Interviews 
will take place at an appropriate indoor venue that is agreeable for both subject and researcher. 
The interviews will be recorded using a digital audio recorder. The interviews will last 30 to 60 
minutes. 
 
Total Number of Participants 
At least 4 individuals will take part in this study at USF. 
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Alternatives 
You do not have to participate in this research study. 
Benefits 
We are unsure if you will receive any benefits by taking part in this research study.   
Risks or Discomfort 
This research is considered to be minimal risk.  That means that the risks associated with this 
study are the same as what you face every day.  There are no known additional risks to those 
who take part in this study. 
Compensation 
You will receive no payment or other compensation for taking part in this study. 
 
Privacy and Confidentiality 
We will keep your study records private and confidential. Certain people may need to see your 
study records. By law, anyone who looks at your records must keep them completely 
confidential. The only people who will be allowed to see these records are: 
 
The research team, including the Principal Investigator, and all other research staff. 
 
Certain government and university people who need to know more about the study. For 
example, individuals who provide oversight on this study may need to look at your 
records. This is done to make sure that we are doing the study in the right way. They 
also need to make sure that we are protecting your rights and your safety. 
 
Any agency of the federal, state, or local government that regulates this research. This 
includes The Department of Health and Human Services (DHHS) and the Office for Human 
Research Protection (OHRP). 
 
The USF Institutional Review Board (IRB) and its related staff who have oversight 
responsibilities for this study, staff in the USF Office of Research and Innovation, USF Division 
of Research Integrity and Compliance, and other USF offices who oversee this   research. 
 
We may publish what we learn from this study. If we do, we will not include your name. We will 
not publish anything that would let people know who you are. 
 
Voluntary Participation / Withdrawal 
You should only take part in this study if you want to volunteer. You should not feel that there is 
any pressure to take part in the study. You are free to participate in this research or withdraw at 
any time. 
There will be no penalty or loss of benefits you are entitled to receive if you stop taking part in 
this study. Decision to participate or not to participate will not affect your student status (course 
grade) or job status. 
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You can get the answers to your questions, concerns, or complaints 
If you have any questions, concerns or complaints about this study, or experience an adverse 
event or unanticipated problem, call Nicholas Fancera (239-898-7936). 
 
If you have questions about your rights as a participant in this study, general questions, or have 
complaints, concerns or issues you want to discuss with someone outside the research, call the 
USF 
IRB at (813) 974-5638. 
Consent to Take Part in this Research Study 
 
It is up to you to decide whether you want to take part in this study. If you want to take part, 
please sign the form, if the following statements are true. 
I freely give my consent to take part in this. I understand that by signing this form I am 
agreeing to take part in research. I have received a copy of this form to take with me. 
 
_____________________________________________   ____________ 
Signature of Person Taking Part in Study     Date 
 
_____________________________________________ 
Printed Name of Person Taking Part in Study 
 
Statement of Person Obtaining Informed Consent 
 
I have carefully explained to the person taking part in the study what he or she can expect from 
their participation. I hereby certify that when this person signs this form, to the best of my 
knowledge, he/ she understands: 
 What the study is about; 
 What procedures/interventions/investigational drugs or devices will be used; 
 What the potential benefits might be; and  
 What the known risks might be.   
 
I can confirm that this research subject speaks the language that was used to explain this research 
and is receiving an informed consent form in the appropriate language. Additionally, this subject 
reads well enough to understand this document or, if not, this person is able to hear and 
understand when the form is read to him or her. This subject does not have a 
medical/psychological problem that would compromise comprehension and therefore makes it 
hard to understand what is being explained and can, therefore, give legally effective informed 
consent. This subject is not under any type of anesthesia or analgesic that may cloud their 
judgment or make it hard to understand what is being explained and, therefore, can be considered 
competent to give informed consent.   
 
_______________________________________________________________     _____ 
Signature of Person Obtaining Informed Consent / Research Authorization Date 
 
_______________________________________________________________ 
Printed Name of Person Obtaining Informed Consent / Research Authorization 
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Appendix C 
 
So the first thing I want to do is I want to define what Direct-to-Consumer Advertising is for 
you.  So you might have some ideas about it already, this might cover that, but I want to 
standardize what you understand as it.  So Direct-to-Consumer Advertising is a pretty unique 
process in that most of the world doesn’t allow it.  Throughout most of the world, in order for the 
pharmaceutical industry to advertise, it can only advertise to healthcare professionals, so 
hospital, physicians who have the education in medicine.  In the United States and in New 
Zealand, there’s Direct-to-Consumer Advertising meaning that the pharmaceutical companies are 
allowed to put out advertisements directly to you, the consumer, so television commercials, 
internet ads, ads in print media like newspapers and magazines, and they’re allowed to tell you 
about new drugs or existing drugs, what they’re for, what they do, stuff like that.  So the Direct-
to-Consumer Advertising at its core is just a direct relationship between you as the consumer and 
the pharmaceutical industry through advertising of products.  Does that make sense? 
 
Yes 
 
Do you have any questions about Direct-to-Consumer Advertising as a concept? 
 
No 
 
Ok, so how would you categorize your personal consumption of various forms of media, so 
internet, television, print? 
 
As far as frequency? 
 
Yeah, would you consider yourself a heavy user, a moderate user, how would you consider your 
consumption of media? 
 
I would say I barely watch TV, I moderately read, like the newspaper or like printed sources, and 
then, the most heavy would be Internet, but I’m not like a heavy Internet user. I don’t have a 
Twitter, there’s a lot of social networking sites I don’t use, but I am on the Internet, you know, I 
do see ads on the internet, but overall, it’s just not a part of my life. 
 
Ok, so how would you characterize your exposure to Direct-to-Consumer Advertising, being 
that, you know, as you’ve said, you’re not a huge television watcher or anything like that? 
 
I would say that the, I see the fewest ads online, just because of a few reasons.  One is I have 
adblock so, I’ve taken steps to not see those ads.  So even though I watch TV less than I’m on 
the internet, I probably am exposed to more advertising on TV than I am through the internet. 
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Ok, talking about the adblock a little bit, is there anything that pharmacy advertisers could do to 
cause you to allow their advertisements to reach you, rather than you blocking them out of hand? 
 
Well, the thing is is that I’m not specifically blocking pharmaceutical ads, I’m blocking ads in 
general, so for a specific advertisement company to do something for me to not block their 
specific ad, I can’t think of any particular path they could take to do that. 
 
OK, is there anything that you, you know, prior to using an adblocker, is there anything that you 
noticed with specifically pharmaceutical ads on the internet that have caused you to put up the 
adblocker to not want to have to see? 
 
No, the reason I put up the adblocker is because I was seeing advertisements to specifically the 
things I was searching on Google, because they collect that information and use it to advertise 
back to you, and I don’t want to see that, so I got rid of it.  The only time I really even saw 
medical advertisements specifically is whenever I had an illness myself, or someone I know had 
an illness and you go on a medical website, WebMD or something like that, and then usually 
sometimes you see medical advertisements on those sites.  But I wasn’t searching medical…the 
thing is, the ads were directed because of what I was searching and I wasn’t searching for 
medical information. 
 
So your exposure to it would have been very low. 
Correct 
 
And so there’s nothing specific that you would have seen in that low exposure situation that 
would have prompted you to block specifically pharmaceutical advertisements. 
 
Right 
 
Ok, now moving forward, what’s your personal…How would you personally characterize your 
perception of the pharmaceutical industry in general? 
 
I’m, I see its usefulness, but seeing as I’m fairly young and healthy and free of medical 
problems, I don’t pay much attention to it, but the advertisements that I do see, I want to avoid 
the products somewhat, because of the taglines at the end where it says it might cause this, this 
and this, but that’s just a little bit unavoidable because health companies have to be transparent 
with what can happen if you take their product, it’s a drug to help you but at the same time it’s a 
product that they’re marketing, so you can’t lie about a product, that will get you in trouble. 
 
Ok, can you think of any kind of, so thinking about your personal exposure to Direct-to-
Consumer Advertising, can you think of any specific ads or specific strategies that you’ve seen 
in ads that you think worked particularly well in either giving you a positive perception of the 
drug or the drug company or left you with the information that would push you toward maybe 
asking for that drug or wanting to be on it? 
 
One specific ad that I can think of, that wasn’t necessarily persuading me to be geared towards 
the drug but, I don’t remember what product it was for, I want to say Xanax but I don’t think it 
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was Xanax, there’s a little happy ball guy rolling along and he’s sad and there’s clouds and, you 
know, he’s getting rained on and stuff and then he goes along and he takes whatever drug it is 
and then he’s happy and he’s having a good day.  I think that that would be effective for a lot of 
people because it’s very simple, you don’t really have to think about what’s being advertised, 
you see it in about as simple terms as you can see it, he was sad and now he’s happy, he’s just a 
little smiley face, but at the same time I think that advertisements like that can be a little…come 
across as if they’re talking down to you, instead of talking to you, because when people go to see 
a doctor, they don’t want the doctor…usually you don’t want the doctor to say, “Take this, it’ll 
help.”  You want him to explain what the drug is doing and why you need the drug so I think, in 
advertising pharmaceuticals, I think a way to make the advertisements effective would be to 
make it simple for the consumer so they understand what they’re getting but at the same time, 
don’t be talking down to them as if they don’t understand. 
 
Ok so, with that in mind, would you say…imagine you’re an advertiser, it’s your job to craft the 
message for whatever drug you happen to be working for, would you say that you would think 
your focus should be more informative, that you need to inform the consumer, or entertainment 
in that you want your message to simply resonate in the consumers mind without getting to deep 
into the details of the drug itself? 
 
I would say it depends on who your audience is, if you’re trying to market your drugs to 
people…this is going to sound bad, but if you’re trying to market your drug to people who have 
a problem, you want to be informative, if you’re trying to market your drug to people to 
convince them they have a problem, you want to be entertaining.  If people are just like “Oh, 
something’s wrong with my life and I don’t know how to fix it” and then they see a drug for a 
mood enhancer or something like that and then they say “Oh, well maybe that will help me,” 
then you want to be entertaining because you want to catch their attention.  But I mean, if you’re 
advertising to people who are really struggling with something and know specifically what it is 
and have been diagnosed and are looking for an answer and are not able to find what works for 
them, you want to be informative and tell them that this is the product that they need and here’s 
why specific to them.  I don’t know, it’s hard for me because I’m kind of immune to advertising 
at this point in my life, but I feel like it would work for most people 
 
Ok, with that like, that’s a pretty strict split right, between two kind of focuses there?  With that 
in mind, are you able to kind of build a general concept of how you personally perceive the idea 
of Direct-to-Consumer Advertising or is it something that’s just too split? 
 
Could you elaborate on that a little? 
 
So, when you think about the Direct-to-Consumer Advertising that you’ve been exposed to and 
think about, you know, one may be for fulfilling the role that you’ve stated of somebody has a 
problem and they want information on how to fix that problem, and another may be we want 
people to treat this problem that we think they have, are you able to kind of…is there a way that 
you can reconcile those two and just think about the state of Direct-to-Consumer Advertising as 
a whole and kind of do you have a specific perception of how Direct-to-Consumer Advertising is 
used in general. 
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Ok, I’m not sure if this is answering your question, but I guess you could just combine the two 
strategies and provide both information and relate to the consumer specifically.  Like for 
instance, let’s not talk about like mood drugs, let’s talk about just like cold, common cold.  If 
people…For instance, there’s a new product, I don’t know how new it is, I don’t use any of these 
very regularly so I don’t know, but there’s like Nyquil and then there’s like Zzzquil now and it 
just helps you sleep, it’s not for cold symptoms specifically.  So I think if you’re advertising 
something like that, you do want to have, you know like they have nasal strip ads too where it’s 
like funny or like Mucinex has the ads, like all these ads where they have the big snot guy, like I 
couldn’t name, I probably couldn’t name any other ones unless I thought about it, any other nasal 
decongestant of the top of my head, maybe like Flonase, I’ve taken that myself when I was 
younger, so for personal experience.  But I do think that creating an image for your product is 
very crucial for anything that you’re advertising, so of course in pharmaceuticals, because the 
consumer is going to recognize that image and associate it with the product and think about that 
product when they’re handling an issue.  So I think that’s important, it is important to sort of 
combine the two worlds and even if you are, you know, trying to be serious about your product, 
creating an advertising strategy that sticks with the consumer is just as important as providing 
them with information, because if you just have a commercial that’s full of…if you just have a 
guy sitting there, telling you what’s going to happen, who’s going to remember that, you know, 
who’s going to remember that advertisement, just information about the product, just a voice 
over of a picture of the product you know?  And even the guy, the Clear Eyes, the guy where he 
does just sit there, and dully explain to you what the product does, they at least made a character 
out of it and created something that you can remember.  So, yeah I think that the two can be 
combined and used effectively, you know just, not just done, but done effectively. It doesn’t 
have to be all gray and monotone and boring, it just has to make sense why you’re being, maybe, 
less serious like Flintstone Vitamins. 
 
Would you say that that should apply across the board or are there…Would you say that there 
are specific drugs that we should leave entertainment out of altogether? 
 
Yea, I mean, I might change my answer if I thought about it for a really long time, off the top of 
my head, I mean if you’re dealing with an issue that’s, you know, like suicidal, people that are 
suicidal, you don’t want to like make a joke out of that or like create a funny, memorable…Like 
if someone’s on the brink of suicide and they’re struggling with depression, they’re not going to 
remember a cartoon about suicidal thoughts, you know?  So I think some of it needs to be a little 
more serious, but I mean, how do you draw that distinction really.  I guess in matters of serious, 
life and death, things that concern life and death shouldn’t be created into an advertising strategy.  
I don’t know, you’re crossing into like moral ideas there. 
 
So basically you’re looking at it as the message needs to be memorable, you need to be able to 
remember what they’re telling you 
 
But also appropriate 
 
Appropriate tonally to the situation 
 
Yes 
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Ok cool, can you think of any advertisements that you’ve seen or strategies that you’ve seen 
employed that were particularly poorly designed, like basically like bad ideas on the part of the 
advertiser? 
 
Well see, if they were poorly done, they wouldn’t be very memorable, so it’s hard to think of 
something.   
 
Well beyond, so like beyond the fact…We can say that not coming up with something 
memorable is a poor strategic choice.  Beyond that, is there something that stuck out in your 
mind, you know, maybe you saw a commercial for a specific drug, and it just stuck out in your 
mind that they did something wrong or somehow colored you to… 
 
Well something that some people would argue that this is an effective advertising strategy and I 
can see that point of you, but something that I would say is not an effective advertising strategy 
is being obnoxious because even if being obnoxious is memorable, this isn’t, this isn’t a 
pharmaceutical thing so it’s not exactly relevant but there’s the like advertisement for like, well I 
don’t even remember it exactly, but it’s like CoolAir or 1-800-Cool-Air or something like that 
and it’s like easy AC is here like call 1-800-Cool-Air or something like that and they repeat it 
like ten times in the commercial in like a sing-song way, and it’s like if my air conditioner ever 
breaks, I’ll never call them because the advertisement’s obnoxious.  So I mean like, if your 
advertising pharmaceuticals, I don’t see why you’d be like obnoxious in the first place, because 
you don’t want to drill pharmaceuticals into anyone’s brain, you know, you just want to present 
them in a way that’s appealing so I can’t think of any specific pharmaceutical ads that are 
obnoxious but if they were to be obnoxious, that would be a terrible strategy. 
 
So basically you want to find the balance between memorable and going overboard 
 
Right 
 
So you’ll always remember this AC company, but that’s not going to influence you to shop there 
 
To use them, right   
 
Let’s see, so thinking about Direct-to-Consumer Advertising and the healthcare industry at large, 
do you think, and if so why, if not why not, do you think that Direct-to-Consumer Advertising 
can be used as a reliable source of information when beginning to gather information about a 
specific drug or a specific problem? 
 
I think it can be a gateway to more specific information, but I think that if you’re trying to 
research a product or a drug to suit your needs, I think that advertising is just that, so yes and no.  
I think that advertising is introducing you to the product but not exactly explain the details of the 
product.  They kind of give you what our product does, this is why it’s better than other products, 
and then very quickly, this is what can result from this product at the end of the advertisement.  
So I think it’s a good introduction but not a good like research source. For example, I have really 
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bad allergies and it seems like every day there’s a new drug for me and I just get burnt out on it.  
I’d rather they just tell me what’s new and let me look up the information if I want to.”   
 
Ok, so, with that in mind, do you think the messaging should be recrafted to be more useful as 
that research tool or do you think it should remain as it is or do you think it should move further 
in the other direction of only raising awareness and not bothering to get into the specifics? 
 
I think you should mention some specifics, otherwise your product is going to be known for its 
name and not for its uses, so I think the usefulness and the effectiveness should be included in 
the advertising.  But, again whenever it comes to the differentiating just between the product 
itself and then information about the product, you can’t just say “Our product is the best, use it, 
it’s more effective than other products.”  You have to specifically say “Well our product reduces 
this, it increases this, it puts you at less of a risk of this, it makes you feel better in this specific 
way or it will suit your specific needs in this specific way.”  Because if you just make blanket 
statements it’s going to blend in with every other product so if you’re advertising your product, 
you need to make sure there’s something like, your product has a niche, like its specific thing 
that is not only better, but different from the other products. 
 
Ok, would you say that the Direct-to-Consumer Advertising that you’re familiar with currently 
fills that role of does it need to change in any ways to fill the role that you think it should? 
 
I think I would need like specific examples for that, because, again in general there’s some that 
do and some that don’t.  Me specifically, I’m feeling healthy and fine so there’s nothing that I’m 
even searching for personally.  So as far as meeting my needs, I’m not paying enough attention 
to the advertisements for my needs to even be addressed so that’s that on that one.  But I feel 
like, if the idea is to inform the consumer, why aren’t the advertisements full of information?  
Shouldn’t there be more details if they’re actually trying to educate us? 
 
Ok, what is your, if you’ve had one, what is your relationship with the pharmaceutical industry 
been?  So speaking of, you know, interactions with pharmacies, with specific drug companies, 
anything like that. 
 
They’ve been mostly positive.  Like I said earlier, I’m only twenty years old, so really most of 
my pharmaceutical things, up until this, you know, a few years ago, you know eighteen or 
whatever, was all handled by my parents anyway.  So I was never really concerned.  As far as 
my interactions in pharmacies, I would go on occasion if I was ever taking anything, but as far as 
currently I’m not interacting with pharmacy, I’m not there.  Any interaction I’ve had is mostly 
positive, I guess I could speak on, like, beyond my personal interaction and the interactions of 
my family, we’ve never particularly had a problem, or we’ve never, you know, nothing wrong 
has ever happened to an extent of causing a problem, enough for me to remember it. 
 
Ok, let’s see. Thinking about new technologies moving forward, what role do you think that new 
media forms like the internet, like social media, should play in messaging for Direct-to-
Consumer Advertising? 
 
I think…from the viewpoint of the companies? 
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Well, you as a consumer, thinking about it as someone who may take part in the, you know, 
social media sites and stuff like that.  What would you see fulfilling a positive niche in that social 
media marketplace for Direct-to-Consumer Advertising? 
I think, personally, I don’t think I have a need for it, but in general I think it’s crucial that, if they 
want to advertise their product, that they become a part of that world.  I mean if you want to 
reach people, the best way is through direct interaction with your consumers.  And again, we 
were talking about earlier, what specific product, you’ve got to careful here, because if you open 
up a, you know…If you’re an anti-depressant company and you start a Twitter account and you 
have people tweeting at you that they’re going to kill themselves or something extreme like that, 
you’re just venturing into a whole nother world of interacting with your consumers on that level.  
But as far as pharmaceuticals in general, I think having a presence on social networking sites and 
on the internet in general is very important.  People communicating with the products that 
they’re purchasing or buying into or being advertised to about, they want to have a way to 
interact with those companies and directly.  They don’t just want to be told what to take or 
what’s right or what’s wrong, they want to be able to confirm it or, you know, directly interact or 
talk to them.  So I think, you know, from their point of view that it’s like pretty…moving 
forward it’s very important that they get involved in the social media and the internet in general. 
 
So, thinking as the consumer, were you to see a, you know, a specific drug have a social media 
presence, in what ways would you think it would be ok to modify their traditional media 
presence.  So, would you think it would be ok for them to change their messaging on television 
with the addendum being that they’re also including the social media presence, or do you think 
social media should only work to supplement what’s already there? 
 
So you’re saying have the television advertising interact with, say a Facebook page or give a link 
to a Facebook page? 
 
Right, I mean like, anything like that, how do you think the two should exist together? 
 
I think using them both is an effective way to reach people.  Personally, if I saw an advertisement 
for, you know Nasonex on my news feed as like a sponsored post or something, I would 
probably think it’s a little absurd, but I think consumers in general would like utilize that, I think 
they would see those things online or like they would see advertisements on the television and if 
whatever it was advertising sparked their interest enough they would definitely…because I 
mean, here’s the thing, if the pharmaceutical company says “Go to our website to learn more,” 
who’s going to go to the website unless they really want to check out the product, you know?  
But unless they’re really researching what they do or don’t need to use, who is just going to be 
on Facebook and be on Twitter and be on all the sites and say “You know what I want to visit?  
This drug company, and just see like what’s going on on their website.”  That’s not so much 
something anybody would do, but I think if people could just type it in their, top of their 
newsfeed or whatever, search a hashtag and just see what’s going on with whatever product or 
whatever drug is being advertised, I think they would be much more likely to… 
 
So kind of, not making the consumer go the extra step 
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Right, moving to the consumer instead of making the consumer come to you 
 
Ok, that makes sense.  One thing I’d like to talk about, because you’ve mentioned it a couple 
times, about the speed talk over the side effects at the end.  What are your specific thoughts and 
perceptions of that specific strategy?  Like what does it make you think of like the drug or the 
company if anything? 
 
I think people will see the advertisement about the drug and be, like, not paying attention maybe, 
you know, and then they’ll hear that thing at the end and it turns people off, because they’re like 
“Man” because it goes on an on, so people are like “Man, how much stuff can,” you know, and 
possibly death, you know like all this stuff that can possibly come from this drug and it’s like, I 
don’t even know if it’s worth it you know?  So I think it’s necessary, because you don’t want to 
just be a little block of text that you have to, you know, pause you’re TV if, you know, if you 
even have that capability and read.  And the people that are being marketed drugs to usually they 
might you know, some of the different demographics, they might not even have the capability to 
slow the TV down or access it on the internet, you know, they might be struggling with 
something.  You know, because drugs aren’t for people who everything is going perfect for.  So, 
you know, so I think that strategy is one that’s necessary, you have to tell people what the side 
effects of your drug are.  At the same time, if you’ve got a bunch of side effects from your drug, 
people aren’t going to want to take it, you know.  
 
So, being that it’s necessary, you know, how would you…Is there anything that you can think of 
that would be able to counter the kind of, the negative perception that you would have hearing 
this fast stream of side effects.  Is there anything that the advertiser can do within the 
advertisement to balance that out and sway perception back to the positive? 
 
That’s a tough question.  I think if advertisers knew how to do that, they’d be doing it already. 
 
Well I mean that’s kind of the goal of this study, to figure out what that is, so…I mean like, what 
would you as a consumer like to see?  You know, you hear this speed talk, do you think that they 
should modify how they deliver that information? 
 
Yeah, definitely 
 
So like what would you like to see as a consumer? 
 
I think it should be slowed down, I think it should, I think if there’s that many things that are 
possible side effects of their products, they need to either like, get back in the lab and make a 
better product or they need to present it in an honest way that like, you know, cut five seconds of 
the spiel about your product and slow it down, tell me what it’s going to cause, you know.  That 
way, even if there’s a hundred things wrong with your product, if people hear it really fast, 
they’re going to be put off by it, if they hear it at a normal pace, they’re going to feel that it’s not 
being snuck into the advertisement, they’re going to feel like, it’s just a part of the product, you 
know, this is just what we deal with with the product, this is what the possibilities are, as 
opposed to, you know a thirty second ad where twenty five seconds of it is “Oh the product is 
great, you’ll feel great, it’s just what you need” and then there’s five seconds of like (mumbling).  
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Like that, I mean like, it’s definitely a good idea to use your time wisely but also don’t squeeze 
anything in at the end, you know, just be honest with your product.  Honesty is a good marketing 
strategy, I mean sometimes people won’t see it that way but if what you’re marketing is 
something that you believing I think honesty is the best way to market it. 
 
Do you think…now would you say that’s you or would you say, in a general sense, people would 
look at it and, if you do, if you’re more open and if you’re more honest about that, would you say 
the general population would see that as a positive or not? 
 
I think, in general, people might not, because I think, with the, I think marketing companies may 
have figured out something here, to where the percentage of people who say “Oh, there’s so 
much wrong with it, I would never want to take that” is not adequate enough to override the 
people that say “Oh, they say that on every drug” and they don’t even pay attention to it.  So I 
mean, for every one that that turns off, there’s probably the same number of people that don’t 
even pay attention to that fast stuff at the end, and just assume that every drug comes with a 
number of side effects and, you know “Oh, none of them have ever happened to me before, so 
I’m not worried about them happening to me with this drug.”  And advertiser might think, well 
those people assume that’s going to be at the end anyway so we need to spend more time pushing 
our product, as opposed to like, expanding on things that like people have heard for years and 
years on pharmaceutical advertisements.  So, it might be me personally, I’m sure there’s 
definitely people on both ends of that spectrum being advertised to. 
 
Well, in a general sense, do you think, so you look at it as negative, it has a negative impact on 
your perception 
 
Yes 
 
In a general sense, do you think that’s the case?  Do you think a lot of people look at that and say 
it’s a negative or do you think most people rush past it and it doesn’t really impact their 
perception? 
 
I would say it’s about, I would say, I couldn’t really say one way or the other, I would say it’s 
probably split.  You know, I don’t have any data to back that up 
 
Right, no just going off of personal feeling, so would you think it would be a worthwhile 
function to find new messaging strategies specifically with these side effects, or do you think it’s 
something that is fine how it is and should be left alone? 
 
I don’t think it’s fine how it is, but I don’t, I can’t think of a better way to both advertise your 
product and…I mean giving it equal say is a good idea, but then, as far as product…I’m sure 
there’s some company that tried it both ways and figured out that one way was better than the 
other based on sales or whatever.  So I think companies are probably doing what’s best for them 
right now. 
 
 46 
 
Ok, would you…looking at kind of the larger scale issue, would you say that the Direct-to-
Consumer Advertising has the ability to kind of determine you perception of the drug company 
altogether, or is it just more localized to the drug itself for you? 
 
I would say it effects the company altogether.  I think whenever you create an advertisement you 
create an image for your company, and then when people are, whenever they hear the name of 
your company, they’re going to think of the people who work there or the progress you’ve made 
or anything like that, they’re going to associate it with an image, the image that you’ve 
advertised with. 
 
So, what kind of effects, like, do you think that Direct-to-Consumer Advertising could effect 
positive perception of the company, say people would trust it more, or could be negative in that 
people don’t trust it?  Do you think Direct-to-Consumer Advertising has the power to influence 
like that level of perception? 
 
Yes 
 
Alright cool.  So kind of, to wrap everything up, is there anything that you, like just personally, 
would like to say that I haven’t asked or that maybe you didn’t get off earlier in the interview? 
 
Something I would add about like the side effects at the end is, and this is just personally, this is 
not speaking for people, but to me, that usually says that the drug has like been heavily tested on 
animals and like, I’m not in favor of like drug testing or cosmetic testing or that kind of testing 
on animals.  So that, whenever I hear all those things at the end, it kind of tips me off to that.  So, 
this is just personally, but if drug companies advertised that their product hadn’t been tested on 
animals, I would be way more inclined to use their product, like 100% more inclined. 
 
Ok, so that’s something that would instantly just, perception way positive, for them to be able to 
say “Yes we did testing, but no it was not done on animals.” 
 
Right, well I think, see the thing with that is like, you’re, I think that’s a positive no matter what, 
because you’re appealing to everyone really.  So you’re appealing to people that are like animal 
rights activists or something like that but you’re also just appealing to the general public who 
don’t think about the fact that maybe their products are tested on animals, but whenever they 
hear a specific product that isn’t, they say “Oh well I’d rather use that one, you know, that’s 
good of them” you know.  Even if people are, don’t particularly care about that political or social 
agenda or whatever you want to describe it as, just thinking of it as a positive, like, for instance, 
there’s like Lush Cosmetics in the mall.  Lush doesn’t test on animals.  Do the people who shop 
at lush care about animals like, you know, in a broad sense probably not, but whenever they go 
to that store, they say, you know “Oh, this is cruelty free” or you know, they use it as a 
marketing strategy.  So I think that’s something that pharmaceutical companies, I’ve never seen a 
pharmaceutical company advertise with that specific, like marketing strategy, and maybe it’s 
because all of them test on animals but I’m saying if I saw that, I would be, like, in mainstream 
advertising, on the internet or on TV, if like, a thing that a major company did, that would be 
impressive to me.  So, and you can apply that to anything, like as far as when marketing goes, if 
there’s something that the company does with their product that no one does with their product, 
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if you push that as your, you know, your point, even if it doesn’t have anything to do with the 
product itself, if you give something for people to feel good about when they’re using your 
product, they’re going to be, and everyone, this isn’t specific to any group of people, but 
everyone is going to be more inclined to use your product. 
 
Right, so kind of like that positive differentiation.  You want to get your name separated, and you 
want to do it in a way that’s positive, whether or not that’s specifically the drug, you just want 
people to think the drug and something good. 
 
Even if it’s like, all of our drugs, or all of our packages are sent with recycled cardboard or 
something like that, people might not recycle or care anything about the environment, you know, 
they don’t have to be an environmental activist to want, to like you company better because 
you’re, you know, looking out for the general welfare or whatever. 
 
Ok cool.  Is there anything else you’d like to talk about or any questions you’d like to ask me? 
 
Nope, that’s it 
 
Alright, well, if that’s the case, I’m going to end the interview now, is that alright? 
 
The End. 
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Appendix D 
 
OK, so the first thing I’m going to do is kind of define what I’m talking about when I say Direct-
to-Consumer Advertising.  So in this country, it’s a little bit unique.  There’s only two countries 
in the world, the United States and New Zealand, that allow Direct-to-Consumer Advertising and 
the more traditional form of advertising is the pharmaceutical industry advertising directly to 
physicians, hospital, stuff like that.  Direct-to-Consumer Advertising is fairly new in the country 
and what it is is the television commercials and, you know, magazine print ads and anything like 
that that you’ll see giving direct information from the pharmaceutical company to the consumers 
themselves.  So this can include anything from radio commercials, obviously the television 
commercials are kind of like the typical prototype Direct-to-Consumer Advertisement, then on 
the internet, you can get things like videos or banner ads and then in newspaper and magazine, 
you know, your standard print ads. 
 
Ok 
 
So do you have any questions about what Direct-to-Consumer Advertising is before we start? 
 
So it’s just basically taking out the middle man, so not giving it to your physician to give it to 
you, it’s just going to you. 
 
Right, it’s having the information come directly from the industry to the consumer. 
 
Ok 
 
Ok, so the first thing I want to know is how would you characterize your personal consumption 
of media, so internet, TV, are you a heavy user of specific media? 
 
I would say social is the big form now especially, I use Twitter a lot so any type of ad that comes 
up on Twitter or that’s retweeted by someone else, that’s a big thing.  And then, I don’t really 
watch a lot of television, but when I do watch television obviously that comes through and radio, 
but I would say social media is at the top. 
 
So would you say you’re not a huge user of, like, print media? 
 
Not as much anymore, because I can get most of it online, but if I’m in, like, an office, and 
there’s like a magazine in there I’ll look at it but I don’t really get magazines or get books or 
anything. 
 
Ok, would you consider yourself a heavy consumer or kind of… 
 
I would say moderate 
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Moderate? 
 
Yeah 
 
Ok, describe your relationship to the pharmaceutical industry, so how you’re familiar with it and 
what interactions you’ve had 
 
So, I did an internship my senior year of high school in a doctor’s office, I was a nursing 
assistant, so I saw a bunch of different things in the office, like whatever like pharmaceutical 
representatives would bring in from the companies, I saw a lot of that.  And then my mom is a 
pharmaceutical sales representative so I see a lot of stuff, or, not as much now that I don’t live at 
home, but when I was living at home, everything that came from her company, I saw, and she 
actually just got hired at a new company so I’m seeing a lot of her new stuff now.  So that’s 
pretty much my main connection. 
 
Ok, how about anything personal.  Have you had interactions with your own…not through other 
people, but say yourself dealing with pharmacy or pharmaceutical companies in any way. 
 
I mean, I like to laugh at the commercials that come on TV when they list like the 20 side effects 
after you take the pill.  So yeah, I would say directly seeing them myself, but nothing more than 
that. 
 
Ok, so mainly your personal involvement is through this Direct-to-Consumer Advertising? 
 
Yeah, I can’t seem to escape them not matter what I do 
 
Ok, how would you characterize your perception of the pharmaceutical industry as a whole? 
 
Say it one more time, sorry 
 
How would you characterize your personal perception of the pharmaceutical industry as a whole, 
like do you look at it positively or negative? 
 
I don’t have a negative outlook on it.  I think that it’s, I would say positive, but not, I don’t like 
praise it, because it’s not something that super affects me that much, but I don’t have a negative 
outlook on it so I would say kind of neutral.  But yea, I think it does what it’s supposed to do, so 
 
Right, so you wouldn’t tend too hard in either direction? 
 
If I had to lean in a direction I would say positive perception 
 
Ok, what about the general concept of Direct-to-Consumer Advertising?  Do you think it’s a 
positive, do you think it’s a negative, what’s your opinion on the fact that it exists? 
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I actually think it’s kind of good in a way, because it allows you to get the information and 
perceive it how you want to, like the consumer, versus like, in this case, if the doctor gave you 
the information, he could be giving it to you in his opinion and then you’re taking it, you’re 
taking his opinion and going with it, whereas you’re not making your own opinion and going 
with it.  So I think that Direct-to-Consumer Advertising is good in a way, just because it allows 
you to make your own judgment and, I mean, it obviously works.  I don’t know if it works on 
me, but it obviously works for most people. 
 
Ok, so looking at it as, kind of, that source of information, how credible or reliable would you 
characterize Direct-to-Consumer Advertising as a source of information? 
 
I mean, I always am skeptical of everything, just because you never know, especially when 
media is involved, what can be construed differently, but I think it’s pretty accurate, I think it’s 
pretty credible coming straight from the source, because, like I said, it doesn’t allow a middle 
man in there and like, kind of, mess with it.  So I think, if it’s coming straight from the company, 
I think it’s more credible than from other parties. I mean, sometimes I feel like it’s just another 
commercial, but if I really think about it, I want to know way more about a pill than about a hose 
that fits in my pocket, and I would want to hear it from the actual company. 
 
Ok, so, have you noticed through, like, your personal exposure to this kind of advertising, have 
you noticed any strategies or tactics that are pretty common throughout Direct-to-Consumer 
Advertising that you might see in any of the commercials or on any banners or anything like 
that? 
 
Usually, those that I see on commercials, like TV commercials, would be, like they try to make it 
look like a regular family, or like they’ll put someone that would look like your grandma or 
grandpa, someone that looks like your brother or sister, something like that so it’s kind of more 
emotional or, like, I mean not really emotional, but it kind of resonates with those people 
because they’re like “Oh, those people kind of look like my family.”  That’s pretty much all I 
have to say about that. 
 
Do you…How does that theme affect your perception, if it does? 
 
I mean, it just, it’s more realistic than someone just throwing facts up there, like if it puts a 
person there and then it’s like a, I don’t know, if they just put people there, it’s more beneficial to 
me, because then I can see, ok it’s really for you, it’s not just like vague stuff. 
 
Ok, so looking at it from that aspect, would you say that you consider it more as a source of 
entertainment, where it’s meant to kind of resonate with the viewer and raise awareness, or 
would you say it’s more of a source of information, where it’s meant to convey specific 
information to the consumer? 
 
I would say it’s both, like they’ll kind of show you, like, at the beginning, like, the people and 
they’ll say, like, what they’re dealing with or whatever, but then it gives you, like, information at 
the end about the drug, like what the drug does, or what the side effects are, like talk to your 
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physician or whatever.  But, so I would say it kind of mixes both, like I don’t think it’s…I mean 
some are a little different than others, but the majority that I see, I think it’s both. 
 
So do you think that’s a good thing, that it should be both? 
 
Yeah, because I think people aren’t going to get the message if it’s just entertainment style, it’s 
just going to be like “Oh, it’s just a commercial” and they’re not going to take it like it an 
information.  But if it’s all information, I wouldn’t listen to it because it’s just facts and statistics 
that are being thrown, like, at me, so then it’s not…it’s just another piece of information that I 
see.  So I think mixing it kind of breaks it up so it’s kind of an attention grabber. 
 
So then, kind of ignoring, you know, there’s going to be certain ones that do it particularly well 
and particularly poorly, in a general sense, would you say that the Direct-to-Consumer 
Advertising that you’ve been exposed to does a good job of finding that middle ground or does it 
fall in one of the two categories too far? 
 
The one’s I’ve seen recently, but I can’t really remember too far, but the one’s I’ve seen recently, 
I would say it does a pretty good job of mixing it because, like, the past, like…I’ve seen multiple 
ones over and over again, but the different companies usually use a similar tactic of mixing, like, 
person, like, personal type things with information, so it helps.  So, I’d say yeah. 
 
Ok, kind of, narrowing it down and looking specifically, are there any specific commercials or 
ads or strategies that you’ve seen used that you thought did a particularly good job of resonating 
with the viewer or allowing the cultivation of positive perception. 
 
Like a specific drug? 
 
It could be a specific drug, or if you just remember the concept of the commercial or anything 
like that 
 
Well usually like, it’s like Cialis or Viagra that are most common, I don’t know why but, usually 
it’s like Viagra or Cialis and like, and they’re usually, like, showing, like, an older couple or 
something like that together.  So I think that’s pretty much most common. 
 
So, do you think that those are…Do those work well in your mind or… 
 
Yeah I think so, because like I said it kind of adds, like, the personal touch, not that I think about 
my family that way, but, like, ok there’s an older couple that, like, can’t do things who younger 
people can do, so it’s like, that’s so sad, so I would say yeah, kind of, yeah 
 
Ok, how about particularly poorly designed strategies or commercials.  Are there any that you’ve 
seen that you just immediately got a negative vibe off of, or that you just think was poorly done? 
 
Yeah, there was, I don’t know what company, but they used cartoons, and it was like animated, 
and I didn’t think that was like appropriate because, like, it wasn’t for kids, so it wasn’t like, it 
was like for, it was an adult medication, but I don’t feel like cartoons, they’re like, necessarily 
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the appropriate way because they just take the seriousness out of it, so it’s just a joke to me, is 
how I perceived it. 
 
Ok, so expand on that, why does that give you a negative perception? 
 
It feels like they want to lighten the mood, but they do it by making it, like, fun, but if the drug’s 
not to make you feel happy, I don’t see…even if it was supposed to make you feel happy, I don’t 
think that you should use cartoons, because it takes the realistic part of it out, like we’re not 
cartoons, so, like, using real people is a better tactic because then people can connect, so cartoons 
are unrealistic. Cartoons just shouldn’t be used.  Drugs are serious so you shouldn’t use 
something silly to sell them,” 
 
Ok, that makes sense.  So you talked a couple times about the side effects right, and that’s 
something that everybody notices and everything.  What’s your personal take on the way they 
deliver, you know, side effect information? 
 
I think it’s somewhat for legal reasons, why they have to give you the laundry list of all the side 
effects, but if there wasn’t a legal issue, I feel like they should just say “Side effects are, like, 
there are side effects when you use this drug, but consult your physician” because I think, like, 
when you’re just, like, rambling on about all these, like, side effects, people are like “Well, why 
the hell am I going to take this drug if there’s like 15 side effects.”  But I think if a doctor could, 
like, explain the side effects, but say the, like, the side effects versus the benefits you’re going to 
get, it’s actually not that negative.  So, just from my personal experience, like, in the doctor’s 
office, but I think, when they give off this, like, laundry list of things at the end it gives it a 
negative because they only hit you with it at the end, like right as the commercial goes off and 
you’re like “Ok, I guess that’s good, I don’t know.” 
 
So you would characterize that particular strategy as cultivating, like, a negative perception. 
 
Yeah, like I said, I think they do it because I feel like it’s part of why…like they have to do it, 
but I do think that it throws in negativity because it’s just like wrong things that can happen if 
you take this drug so yeah.  But I mean they all have it, so it’s not like one company looks better 
than the other because they all do it, but I think it gives a negative effect. 
 
Ok, if, you know, government regulations off the table, how would you, if you were designing 
the message, convey that information in a way to counter the negative perception that is attached 
to the current strategy? 
 
I think it would depend on the drug itself, like what…because, like, I know there are some drugs 
that you can take that do give you side effects, but like, you can offset the side effects by taking, 
like an extra vitamin a day or something like that.   So, I would just, I don’t know, I would leave 
it at the physician’s hand at that point, like I wouldn’t really specify it on the TV or on the 
commercial, because it just gets confusing and then consumers will say, like “Ok, I don’t know 
what they’re saying, I’m just going to ignore it,” but if they just say something like, leave it very, 
I don’t want to say vague, but kind of vague, and then just put it, kind of in the hands of the 
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physician, because then the physician can kind of bring it down to layman’s terms, like help 
them figure it out a little better. 
 
Ok, so then would you say the purpose of…What would you say the purpose of Direct-to-
Consumer Advertising should be? 
 
Just to get the name of the company or the drug out there and give a brief description of what it 
is, so that they can question themselves and their physicians about why they should use it.  So 
just like a brief synopsis of the drug, but not the negative, because I feel like they should be 
positive to get more business. 
 
So, kind of, as a concept, would you say, looking at it from the consumer’s standpoint, would 
you say that being able to receive Direct-to-Consumer Advertising ultimately has a positive, 
negative, or no effect on you as a consumer of pharmaceutics? 
 
Positive 
 
Positive?  How come? 
 
Because I like to see things for myself, so like, I want to be able to make the decision on my own 
if it’s going to be, like I want to be able to make the decision, like, for myself, like I don’t want 
the doctor to tell me “Well, this is what the drug does,” like I want the company to tell me. 
 
Ok, so thinking about the ways that the message can be, kind of, conveyed to you, do you 
think…what part do you think that new media and social media can play in altering strategy in 
coming up with messages? 
 
I think, I’m thinking of Twitter because that’s what I use, so if like I’m using Twitter and there’s 
an ad or tweet or whatever from the company about the drug, I feel like it’s easier on a social 
media site, because Twitter really allows you to give, like, you can respond to that tweet, and 
like, throw something out there and there’s a pretty good chance that someone from the company 
or someone that’s related to the company could respond with your answer.  I feel like it’s more 
beneficial on social media, but I don’t know if that’s the question you’re asking. 
 
Well, basically, what do you think the roll of social media should be?  Do you think that these 
drug companies should use it, should they not use it? 
 
I think they should use it more, because social media, because it’s linked to the web, allows for 
them to put their drugs or whatever out there and then connect a link to more information from 
the company, like they can put like online brochures or online, like, pamphlets that they would 
usually give in a print form, they could give it, just straight online, and then it’s just easier, it 
would allow the consumer to have more research at their fingertips easier, so they don’t have to 
do more work, it’s all right there.  So I think social media, especially Twitter, would be 
beneficial to the company. 
 
 54 
 
Ok, so do you think that employing social media as a part of your messaging should have an 
impact on how more traditional forms of Direct-to-Consumer Advertising or do you think that 
they should exist where what we see now should stay the same and with the supplement of social 
media? 
 
Yeah, I think radio, TV, like, those should stay the same because most of your traditional users 
of TV and radio are going to be like using it in the same sense of like past time, are going to be 
your older consumers who like, have been watching the same thing over and over again, so that’s 
what they’re used to.  I think it can be, I think they can be more creative commercials, but 
not…but still keeping to the original message, but I think they could be more creative, and then I 
think they could implement like “Follow us on Twitter” or “Check out our whatever” like their 
social media, out there on the radio or TV so that you can kind of get both crowds.  But I think 
that it should be, I don’t think that TV and radio should be altered too much because you don’t 
want to lose the effect that you’ve been having. 
 
So, looking at it, again as the consumer, right, and looking at the, kind of, Direct-to-Consumer 
Advertising that you’re currently exposed to, what would you say, if anything, is missing that 
you wish, either they, the messaging would do differently or would be added or subtracted from 
what you currently are exposed to? 
 
Hmm, that’s hard.  So what I would change… 
 
Right, about your current experiencing 
 
I would just say like try to make it a little more creative so that you’re sticking with your original 
form of getting viewers through TV or radio, whatever but still adding in a more creative…I 
don’t know, our younger generations are so hands on interactive that I feel like there should be 
something that works with that, so you’re getting, I don’t know, more people to feel what you’re 
doing 
 
So you think there should be maybe more of, like, a dialogue between the company and the 
consumer? 
 
Something, yeah, something that reaches more to the consumer.  Like I think they do a decent 
job, like I said, I don’t have, like, a negative outlook on them, but I think they could do more to 
reach out to a generation that’s evolving, like because we do so much with social media and, 
like, that kind of stuff, they should pull into those type of things 
 
Ok, thinking about like the uses of Direct-to-Consumer Advertising, if you’re in the shoes of the 
pharmaceutical industry, and you’re trying to put out an ad, what do you think the main focuses 
are?  What are you trying to accomplish? 
 
Well, you want to attract the consumer that has this issue, so whatever the things is, so you want 
to attract them, and you want them to have a positive outlook on your company, so just making 
sure that there’s more positives in your ad than there is negatives and like, and there’s no room 
for, like, a negative connotation to be brought about, and like, so yeah. 
 55 
 
 
So, thinking about that, instead as the consumer, what are you trying to, like, what’s the main 
goal that you would be trying to get out of a Direct-to-Consumer Advertisement?  Say you had a 
specific condition and there were two opposing advertisements, what would make you drawn to 
one over the other? 
 
I think that, kind of, drew more to a personal emotion, so taking this drug could do this, this and 
this for you, something that makes me feel good about taking the drug.  Like I feel comfortable 
taking the drug. 
 
So you kind of want to focus more on the person than on the drug or whatever is being treated, 
you want it to focus more on… 
 
Yeah, I think making it more personal just allows the consumer to be like “They actually care 
about me” so anytime a company puts, like the care, puts it on the consumer, like we’re doing 
this for you, I feel like they have a better outlook on the company, and that’s with everything, 
whether it’s drugs or not, but I feel like if they care about the consumer, the consumer is going to 
care for the company. 
 
Ok, and then, kind of thinking about everything that we’ve gone over, what level of…do you 
think that there is a level of interaction between the consumer and the pharmaceutical industry in 
Direct-to-Consumer Advertising as it exists currently? 
 
I don’t think there’s a direct interaction through Direct-to-Consumer Advertising, but I think 
there are certain ways that are…like I mean like, they put their phone number on there so you 
can call them, or some of them have their websites on their commercials so the consumer can 
look their stuff up, but I think most of their interaction is through the doctors because, you know, 
like when my mom goes to the doctor’s office, she’s giving them stuff, like study material 
basically to teach their patients.  So I would say that mostly, their main interaction is through 
their representatives but through direct advertising it’s more of just “Here’s a phone number if 
you have direct questions but consult your physician,” they always say that, so I would say it’s 
an indirect 
 
Do you think that’s a good thing for them to say, “consult your physician?”  Do you think that’s 
ultimately…How does that effect your perception as a consumer when you hear a statement like 
that? 
 
I guess it could depend on what the drug is for, on like what condition it’s for, like some 
conditions are going to be much more serious than others, but like if it’s something, like a drug 
for your heart of course, I think that they could make it…like that kind of sounds, if they’re 
saying, like, “If you have any questions, consult your physician” it feels like, we don’t really 
know what the drug does but your doctor can explain it to you.  So I think that if they were more 
like, put it more, like, on the company, just like “If you have concerns or whatever, don’t hesitate 
to go on our Twitter, go on our Facebook, or go on our company website, or call us” and then 
they’ll answer it, and then if they call them and they don’t…because a consumer is going to ask 
their doctor if they want, so I don’t think that that’s necessary to put on there, because it’s just 
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like, it’s the person that they feel can answer it best is probably their physician, but I feel like, 
it’s almost like, your like, placing the responsibility on someone else.  But I don’t think it’s a bad 
thing to ask a physician because they do know what they’re doing, but I don’t think they should 
just put it on the physician because, like, it kind of shows like, either a lack of care or a lack of 
knowledge 
 
Ok, so how would you fix that?  If you were in charge of overcoming that particular perception, 
how would you go about it? 
 
Taking the emphasis off of “Consult your physician” like I would, I probably wouldn’t even put 
that in the ad.  Like I wouldn’t say “Consult your physician,” I would put like all of our, as the 
company, I would put all of our information on there, like contact information, like maybe, like 
usually companies have like a help email address that you can like send things to, like that kind 
of stuff on there, like a phone number, or like a help line, something like that, and then whenever 
they called the company, at that point they could say like “Well this is what we have for you, we 
can send you information, or your nearest doctor that specializes in this could probably answer 
those questions too if you don’t want to wait.  So then, just taking off like the additional 
emphasis on the physician, and then later, like if the question still can’t be answered, then saying 
“Well, your physician…”  If they don’t go to their physician first, but I don’t think that the ad 
should say “Contact your physician,” it just kind of puts it off on someone else. 
 
Kind of, in a really general sense, do you have any thoughts about, kind of specific thoughts or 
specific strategies that you would want?  Things you would want to see or hear or experience, 
regardless of how realistic or likely they are to happen, do you have any kind of thoughts about 
what you would like to see that you cause you to instantly think more positively about whoever 
the company is that’s advertising? 
 
Well the main thing is just, I mean I haven’t seen too much of it, but like the cartoon aspect.  I 
just think, tailoring your ad to the level of seriousness that it needs to be tailored, so not trying to 
make a heart commercial, like a heart drug commercial, like fun.  Like I mean I think it should 
be interesting, but there’s other ways to do it versus making it like “Oh, it’s such a good time, 
take this drug,” because obviously if you’re having heart issues, you’re not, like, having fun.  So 
I think just making sure that the advertisement conveys the message that you’re trying to convey, 
that would be my main thing.  I don’t really have any other…I think they do a pretty good job, 
just some companies, I think, try to make it more entertaining, or more, like, appealing to the 
consumer, but they do it in the wrong way. 
 
And then, just to wrap everything up, is there anything that I haven’t asked you or that you 
thought of, that you want to talk about, you know, beyond my specific questioning? 
 
No, I don’t think so.  They’re all pretty good.  You did a good job 
 
Thanks 
 
No but I don’t think so. 
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Ok, are there any questions that you have for me to clarify anything we talked about, anything 
like that? 
 
No 
 
Alright cool, in that case I’m going to end the interview now. 
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Appendix E 
 
The first thing I want to do is I want to define what Direct-to-Consumer Advertising is for you.  
So you might have some ideas about it already, this might cover that, but I want to standardize 
what you understand as it.  So Direct-to-Consumer Advertising is a pretty unique process in that 
most of the world doesn’t allow it.  Throughout most of the world, in order for the 
pharmaceutical industry to advertise, it can only advertise to healthcare professionals, so 
hospital, physicians who have the education in medicine.  In the United States and in New 
Zealand, there’s Direct-to-Consumer Advertising meaning that the pharmaceutical companies are 
allowed to put out advertisements directly to you, the consumer, so television commercials, 
internet ads, ads in print media like newspapers and magazines, and they’re allowed to tell you 
about new drugs or existing drugs, what they’re for, what they do, stuff like that.  So the Direct-
to-Consumer Advertising at its core is just a direct relationship between you as the consumer and 
the pharmaceutical industry through advertising of products.  Does that make sense? 
 
Definitely 
 
And how would you characterize your personal consumption of various forms of media? 
 
I would say I’m a moderate consumer, like I’m not watching TV or whatever all the time, but at 
least once a day I like to check in with different stuff, to see what’s going on on the internet or 
TV 
 
Alright, so what would you say is your primary source of media? 
 
The news, and the internet mostly.  I watch a lot of news and I always have my phone an laptop 
with me so I always have the internet. 
 
What about Print? 
 
I don’t really do any print stuff, like I don’t read the newspaper or anything. 
 
And DTC advertising specifically? 
 
I would say I’m a heavy consumer, I guess?  Like it’s kind of everywhere so it’s hard to not be 
 
Ok cool, and what about your personal relationship with the pharmaceutical industry, meaning 
family or friends in the industry or your personal interaction? 
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I don’t have and family in the industry, but I take prescriptions and go to the doctor and 
everything, so I would say I have a normal relationship.  I mean, I usually only interact because 
something is wrong, but it’s a casual, straight-forward thing.  I see my doctor, he tells me what I 
need to take, why, and the risks, and then I take it. 
 
So would you say your doctor is a primary source of information on medication? 
 
Yea, but there are definitely other sources 
 
Would you consider DTC advertising a source? 
 
It is a source but it’s a biased source of information.  It’s an advertisement to sell you a product, 
the main goal is to sell, so it’s not something I would rank as highly as my doctor. 
 
Thinking about DTC as a concept, what is the main purpose in your opinion? 
 
Advertisers want you to buy their drugs, plain and simple.  They want to sell more of whatever 
they’re selling than other companies and will tell you what they think you want to hear. 
 
How would you rank your exposure to DTC advertising? 
 
Very high, it’s all over the TV, I see some of it on the internet, but I could quote you Viagra, 
Cialis and Levitra TV commercials.  So I would say I have a high level of exposure. 
 
Noting that you have a high level of exposure, can you identify any specific ads that you have 
seen that you think were done particularly well? 
 
Yea, I would say Lunesta, the one with the butterfly. Well and of course there’s Viagra.  They’re 
all about establishing the man as “the man” and trying to tell men, this is something to help you 
be a man again.  It’s a really well done commercial. 
 
What strategies do you think were important in those commercials when they were being 
designed? 
 
I think understanding their audience, like they got to the root of what they were selling, asking 
what the target audience wanted and how they could give them what they wanted.  I think they 
did a good job of understanding that and delivering.  Like basically with Viagra, they were 
saying how can we make this appeal to men?  And we want to help men.  We want to help you 
be the man you are or that you see yourself as. 
 
As a consumer, what do you want to see in messaging aimed at you that would make you view 
the drug positively? 
 
I don’t want to feel like I’m being sold something, even if you know you are, I want the 
commercial to relate to me, who I am, and what I’m going through.  It has to be personal.  A 
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prescription drug is something that has a big, long-term impact on you, so I want to feel like it is 
personal to me and that I am being though about. 
 
That makes sense.  Kind of changing direction, thinking about the different advertisements 
you’ve seen, are there and common elements that you can identify across the board.  Like 
regardless of what the drugs are for, is there anything that always pops up? 
Quick side effects, that’s something in every commercial ever.  You listen to a minute of how 
great and amazing the drug is and then you get three seconds of someone listing a million side 
effects. 
 
How do you perceive that? 
 
Like, the company is just saying let’s just get through this, let’s hide it, we don’t want you to 
remember it but have to say it somewhere.  I feel like, if they didn’t have to put that part in, 
they’d be very happy. 
 
And does that change your perception of the drug or the company? 
It makes me feel that there is more risk than they’re willing to admit because it’s trying to be 
hidden.  It’s a definite negative for me, the way it’s done now.  If I heard it from a doctor, I 
might be more ok with it, but the commercial is already trying to sell me something and then 
tries to hide it. 
 
How do you think this could this be fixed, or maybe how other negative strategies too, could be 
addressed and fixed? 
 
The commercials are so positive sometimes, maybe there should be more similarities in the 
commercials themselves and what they are trying to fix.  Like if a company comes out and says, 
”there are issues, here’s how we can help.”  Plus now they say talk to a professional, which helps 
but should have more focus than just one line in the commercial. 
 
Do you think doing those things would be enough? 
 
There needs to be a lot more for me, but for a lot of people, that probably does enough to say be 
careful, don’t take this lightly.  Which is better than everything is positive and then oh yeah by 
the way you might die or have a heart attack or something. 
 
What about bad commercials?  Are there any DTC advertisements that you would say are 
particularly poorly done? 
 
Definitely, there’s an Allegra commercial that just has a CG bee flying around with a French 
accent.  I thought it was stupid and the commercial itself was just stupid and not memorable.  It 
did nothing for me.  And the cartoon wasn’t the problem, some cartoons are better and seem 
serious, like maybe more grown up, but this felt childish.  And I have allergies but it didn’t 
connect with me, it just seemed silly.  Meanwhile I don’t have erectile dysfunction but the 
Viagra commercial sticks out because it was well done. 
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Changing gears a little, what do you think of DTC advertising as a source of information? 
 
The commercials are a terrible source of actual information; they say what they think they have 
to say.  Online ads seem to do the same thing, there’s not a lot of credible information, just an 
advertisement.  I wouldn’t use it to compile information for myself, beyond it letting me know 
the drug exists.  I would talk to my doctor. I mean, if f I’m going to take a new drug, I want to 
hear a doctor or someone who has gone to school for a long time.  I don’t want to hear a TV star 
from the 70s or a Hollywood actress with arthritis.  It just feels manipulative.”   
 
What if you’re the advertisement creator, how would you design an advertisement? 
 
Putting a doctor in front of the camera and telling the pros and cons, someone with credibility 
presenting an unbiased view of the actual drug.  I would focus mostly on information and just 
telling people why they might want to use my drug but still giving the whole picture.  I don’t 
know how you do that entertainingly though. 
 
With that in mind, where should the focus be?  Entertainment or Information? 
 
The commercials should have a focus on facts, but maintain an entertainment slant. There needs 
to be a focus on advising that people talk to their doctor and take things seriously, not just 
jumping into anything but there should be a good balance presented in an honest way. 
 
Thinking about everything we’ve talked about, what is your perception of DTC advertising? 
 
It’s selling a product, plain and simple and there should be a shift to informing the consumer and 
keeping them safe. 
 
Anything else that we haven’t talked about, maybe that you wanted to say and I didn’t bring up? 
 
Nope, not really. 
 
Ok, then I’ll end the interview here. 
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Appendix F 
 
I want to define what I’m going to be meaning as Direct-to-Consumer Advertising.  So, the 
United States is a little bit unique in that most of the world doesn’t allow direct advertising from 
pharmaceutical companies to the consumer.  It’s still pretty new in the United States, it’s only a 
few decades old and basically it’s anything you see on, you know, the TV, the internet, print, 
anything like that that is advertising a specific drug, messaging from the pharmaceutical 
company itself.  So, you know, Levitra, anything like that, that’s what we’re talking about when 
we say Direct-to-Consumer Advertising.  Now, the main thing most people think of is the 
television ads but it’s important to also recognize that when you see it in newspapers, magazine, 
print ads, when you’re on the internet if you see videos or if you see banner ads, anything like 
that sponsored or brought to you by the pharmaceutical company itself, they’re Direct-to-
Consumer Ads, and then on the radio, if you hear a commercial for whatever.  So, I mean, it’s a 
pretty simple concept, but do you have any questions about Direct-to-Consumer Advertising as 
an idea? 
 
Not really, it’s pretty straightforward. 
 
Ok cool, so let’s start with, how would you characterize your level of consumption of various 
types of media, so internet, television…? 
 
How would I categorize it?  I use the internet and television pretty much the most and then radio 
every once in a while but not a whole lot. 
 
Ok, how about print? 
 
Print, yeah about the same as radio.  Not frequent, but once in a while. 
 
So you would say you’re like predominantly internet and television? 
 
Yeah 
 
Would you consider yourself a heavy user of media, internet and television, stuff like that? 
 
Yeah, I mean what would you define heavy? 
 
I mean, it’s really subjective, it’s just do you consider yourself to be someone with regular, high 
level exposure to, you know, internet, radio, television, anything like that? 
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So yeah, I would say heavy 
 
Ok, so with your exposure to different types of media, how would you categorize your exposure 
to Direct-to-Consumer Advertising?  Like what’s your familiarity with it? 
 
I would probably say my familiarity comes from the television mainly, I see like the dumb 
Viagra commercials and Cialis, like this is dumb.  But like for internet and print and all that stuff 
I kind of ignore advertising, especially if it’s, like, on Youtube where if it’s on the ad and you 
have the option to skip it after like five seconds. 
 
So basically your relationship with Direct-to-Consumer is through the TV? 
 
Yeah 
 
What would you consider your perception of the pharmaceutical industry? 
 
Like in what way? 
 
Like, do you…as an industry, do you view it as a positive, it does good things, as a negative, it 
hurts people or deceives people, or you can say you don’t have a particular perception. 
 
I’m kind of neutral, I mean, I understand that there’s some pharmaceuticals that help people, but 
then there’s also, these companies have their own incentives, to sell things, so I mean it depends 
what side you look at it from but overall I see it neutral. 
 
OK, what level of personal interaction have you had with the pharmaceutical industry, so not 
getting into specifics but what is your experience with prescriptions or dealing with the 
pharmaceutical industry? 
 
Normal I guess, like I see the TV ads, and take prescriptions and everything. Like I’m not sick or 
anything, just normal prescriptions, so I wouldn’t say a ton of interaction, just like normal 
 
OK and what is you perception of the industry? 
 
Mostly positive I think, positive or neutral, but maybe a little negative just because of the price 
of drugs.  Like they’re so expensive and how are people without insurance supposed to afford 
their medication?  But aside from that, that’s the only negative 
 
Shifting focus a little bit, can you think of any examples that you would call a particularly well 
done commercial? 
 
Not really, I mean most are either very corny like Viagra, or really ambiguous, like a woman on 
a mountain for birth control, like really out there. 
 
Are either of those good or do you think they detract from the intended message? 
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Well, I mean the corny commercials stick in your mind and tell you what the drug does, so that’s 
good, but the ambiguous ones are definitely detracting, like they don’t tell you anything about 
the drug and you have no idea what they’re actually telling you. 
 
Ok well, imagine that you need a prescription, would you use DTC for information? 
 
No, they are just commercials, they even tell you to talk to your doctor for the real information.  
Like I might take their advice and talk to my doctor, but that’s the only real information I see. 
 
Do you like that?  I mean, are do you like that the commercials focus more on the commercial 
than the information?  Should they be entertaining?  
 
I think they should focus more on information but I don’t really know how to do that.  I mean, 
you need the entertainment side and can get someone with a good hook, but I don’t really know 
how to include the information without losing your audience. 
 
Well, how would you design an advertisement? 
 
I would put an entertaining hook at the beginning but then transition into real information, kind 
of like an even trade-off.  The corny commercials can sometimes pull me away from paying 
attention, so I just want that good first hook and then actually educate the consumer rather than 
stay corny throughout the whole thing 
 
With that in mind, how are current advertisements in your opinion? 
 
They are either informative or entertaining but not both.  Like sometimes the information part is 
just thrown in at the very end in like really quickly reading the side effects and there needs to be 
a lot more balance. 
 
Speaking of that, what do you think about that particular strategy? 
 
It’s kind of just the company covering their backsides. 
 
Do you see it as coloring your perception? 
 
Yes, negatively, the companies are just covering their backsides, just getting it done and out of 
the way so they won’t get sued.  They’re not really trying to offer information to the viewer. 
 
So how would you fix it? 
 
That’s hard to say because I feel like it’s necessary but I don’t how to fix it.  Like when I hear it I 
think like “forget that,” but maybe if they didn’t rush through it, I wouldn’t think about it so 
negatively. 
 
So overall, how do you perceive DTC advertisements right now? 
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They can definitely improve but could be doing way worse.  I want the companies to do an even 
better job, be more transparent maybe, but they are kind of doing well right now.  Maybe they 
could use social media, by pointing to social media in commercials for more information, maybe 
giving more time for the side effects at the end also, but for the most part, it’s not too bad. 
 
And just to kind of tie everything up, is there anything I haven’t talked about or anything that 
you might want to say. 
 
Not really, nothing I can think of. 
 
Ok then, umm, the end. 
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Appendix G 
 
Alright so the first thing I’m going to do is define what Direct-to-Consumer Advertising is as a 
concept.  At its core, DTC means that the pharmaceutical company is allowed to advertise 
straight to you, the consumer, as opposed to communicating only with healthcare professionals.  
The advertising can be done through various types of media, meaning TV and radio commercials 
or print and internet ads.  This is different in the United States from around the world as only the 
United States and New Zealand currently allow DTC advertising.  As a concept, this is fairly 
new, starting in the past few decades and has increased in recent years.  Any questions about 
DTC advertising as a concept? 
 
No 
 
So starting off, how would you describe your level of consumption of media? 
 
I would say I mostly use the internet, some radio and TV, but the internet is my main, like, type 
of media 
 
What about print media like newspapers? 
 
Not really newspapers, but I read a lot of magazines 
 
And what is the level of you consumption?  Heavy, moderate, light? 
 
Heavy, definitely heavy 
 
And how about your personal exposure to DTC? 
 
Pretty high, I see a lot in magazines and TV mostly 
 
Is there a higher amount of DTC through those types of media? 
 
Yes, like it seems like most commercials or like flipping through a magazine, it seems like 
mostly pharmaceuticals 
 
Why do you think your consumption is highest there, even though you use internet the heaviest? 
 
I don’t know, there just seems to be less online.  Maybe so you don’t buy drugs on the internet 
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And beyond DTC, what is your exposure to the pharmaceutical industry? 
 
I’ve had health problems for most of my life and so I’ve done research on that so I would say I 
have a pretty high exposure.  I mean, probably higher than most people probably. 
 
And as a high exposure person, what are your thoughts about the industry as a whole? 
 
I see it as a marketing industry mostly, trying to sell products to a consumer, that way the 
company makes more money 
What do you think about the industry from the healthcare standpoint? 
That there is definitely a side that wants to do good as far as health goes but I think that it’s still a 
business and that sometimes maybe the desire to help people is a little bit overshadowed by the 
desire to do business 
 
That being said, do you think that fact influences the messages that are put out? 
 
Well like specifically, there is a commercial for a psoriasis medication, I forget what it’s called, 
that, they do a really good job.   Like instead of where other commercials tend to say a lot of 
stuff that does not really seem to be relevant to the virus or the drug, this commercial showed 
like someone suffering from psoriasis and then showed the, like, patches starting to disappear, 
which I thought was good. 
 
So looking at that commercial, would you say that did a particularly good job of resonating with 
you, like they did well in communicating their message to you? 
 
Definitely, like I came away from that commercial knowing what the drug was for and it 
showed, like, a realistic view of the disease.  Like a lot of commercials tend to show a picture of 
someone smiling and happy and then blah blah blah, it will kill you at the end and I didn’t get 
that feeling from this commercial. 
 
OK, so mentioning that, you know you have the list of side effects down at the end, how does 
that specific part of the commercials color your perception of the commercial or the drug or the 
company? 
 
I mean, you put a lot of stuff in your body that causes all kinds of side effects without telling you 
so it’s definitely not bad.  Plus, nobody really learns anything from this stuff, it just makes them 
think they know more that their doctors.   There’s not enough information to be helpful, just 
misinformed. I don’t even necessarily think I want that information, like, I don’t need to know 
how it works or how many extra hours I’ll be able to sleep or whatever, I can look that up, but I 
would like to know if the drug will cause my hair to fall out or give me a heart attack.  It 
shouldn’t just be this tiny font or someone speed-whispering at the end of a commercial. 
 
So ultimately, for you at least, you think it’s an important factor. 
 
Yeah 
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What about, thinking about the general population, not you specifically?  Do you think the 
general population would have a changed perception based on this? 
I think so, I think some people might be more hesitant, or think more negatively about the drug 
after hearing that. 
 
So how would you reconcile that?  How would you make up for that negativity? 
 
I might instead say, “Talk to your doctor about side effects.”  Like instead of a list, just say talk 
to a doctor. 
 
What are other strategies that you might be able to identify from DTC advertising? 
 
Well I feel like some commercials try to paint a picture of that taking the drug will make your 
life more perfect. 
 
Do you think this has an impact on perception? 
 
I think it does, I think even if people aren’t meaning to, they can probably associate the good 
feelings in the commercial with themselves and so I think it makes them see the drug more 
positively. 
 
What about negative? 
 
I think this old Zoloft commercial, it showed this woman in a robe and like really depressed and 
then said “This will help you not be depressed.”  And I think the current commercials do a better 
job by being more positive. 
 
And in a general sense, what do you think has a bigger impact on perception, the commercial or 
the actual drug itself? 
 
I think ultimately the drug itself, but a commercial might be able to influence you to get the drug 
in the first place, so I think they’re kind of tied together. 
 
And do you think the commercials have the ability to shift perception on, not just the drug or 
company, but on the industry as a whole? 
 
I definitely think so because I think people are, I don’t want to say impressionable, but people 
are kind of easily swayed.  So if you do a good job, you can completely change how someone 
views the industry I think. 
 
Ok, so for a minute, put yourself in the shoes of someone designing a DTC advertising 
campaign.  What would be your ideal commercial?  Kind of map out for me what would be 
perfect to you. 
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I don’t know, like I keep going back to the psoriasis commercial, like it was pretty spot-on.  You 
just have to show the person suffering from the disease in a real life setting that can appeal to the 
most people.  Like you have to be realistic about it, portray the drug being used in a real life 
setting. 
 
So looking at that, you kind of have marked two very different commercials: one that is very 
straightforward, tells you what the drug is for and shows a real situations and one that is more 
entertaining, where it’s the drug’s name and then not really much other relevant information. 
 
Yeah 
 
So what are your thought about how those two ideas, kind of information and entertainment, 
should work together to build the commercial?  Like what is the balance? 
 
Across the board, I think it should be based more on information, but maybe that’s just me.  I 
know that when you’re watching television, most information would just pass over someone’s 
head, but for me, I want the more information. 
 
So what do you think the two sides have to offer to a commercial? 
 
Well like the entertainment side can give you the positive feelings and the information can give 
you the information, which is also a positive. 
 
And what about negatives? 
 
Well the entertainment has a problem with people just not knowing anything about the drug, but 
then the information has the potential of just boring people and them not caring about the 
commercial. 
 
And kind of, to wrap up, is there anything else that I didn’t mention or that you might want to 
talk more about? 
 
No I think you pretty much covered how I feel about the industry and everything. 
 
Alright then I’ll end the interview here. 
 
OK
 
